Embed
Email

Process

Document Sample

Shared by: cuiliqing
Categories
Tags
Stats
views:
0
posted:
11/11/2011
language:
English
pages:
29
Table of Contents

Section E: Transplant Process





E.1 New patients on wait list

by age, gender, race, ethnicity, primary diagnosis, transplant number, blood type, & PRA





E.2 Median wait time

by age, gender, race, ethnicity, primary diagnosis, transplant number, blood type, & PRA





E.3 Total patients wait-listed for a kidney

by age, gender, race, ethnicity, primary diagnosis, transplant number, blood type, PRA, & vintage





E.4 Percent of prevalent dialysis patients wait-listed for a kidney

by age, gender, race, ethnicity, & primary diagnosis





E.5 Percent of patients wait-listed or receiving a deceased-donor kidney within one year of their ESRD initiation date

by age, gender, race, ethnicity, & primary diagnosis





E.6 Renal transplants: by donor type





E.7 Renal transplants: recipients age <20

by age, gender, race, ethnicity, donor type, number of transplants, & blood type





E.8 Counts of renal transplants, by donor type

by age, gender, race, ethnicity, primary diagnosis, blood type, & PRA





E.9 Renal transplant rates: by donor type

by age, gender, race, ethnicity, & primary diagnosis, per 100 dialysis patient years

Footnotes





for entire chapter:

Adjusted rates use the 2005 ESRD cohort as reference.

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.

*Values for cells with 10 or fewer patients are suppressed.

"." Zero values in this cell.





E.1 Age is calculated as of December 31 of each calendar year.





E.2 Age is calculated as of December 31 of each calendar year.





E.3 Age and WL status are calculated as of December 31 of each calendar year.





E.4 Point prevalent patients on December 31 of the given year.

Age is calculated as of December 31 of the given year.





E.5 Age is calculated as of the day of ESRD initiation.

USRDS counts include non-Medicare patients.





E.6 USRDS counts include non-Medicare patients.





E.7 Age is calculated as of the day of transplant.

USRDS counts include non-Medicare patients.

Blood type is not available until 1988.





E.8 4161 transplant events (1.2%) were dropped from the donor type-specific tables above due to unknown donor type.

Age is calculated as of the day of transplant.

Donor relationship, blood type, and PRA are not available until 1988. Donor and recipient serostatuses are not available until 1996.





E.9 4161 transplant events (1.2%) were dropped from the donor type-specific tables above due to unknown donor type.

Age is determined as of January 1 of each calendar year.

Donor relationship is not available until 1988.

Table E.1

ESRD-certified patients added to the kidney or simultaneous kidney-pancreas waiting list

by age, gender, race, ethnicity, primary diagnosis, transplant number, blood type, & PRA



1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996

<1 . . . . . . * * 16 15 12 13 11 15 12 * *

1-4 * . . . * * * 28 27 31 34 34 40 32 26 45 51

5-9 . . * * * * 13 60 72 63 68 75 80 68 58 72 83

10-17 * * * 11 18 28 58 194 300 257 253 275 279 268 240 312 323

18-29 14 19 26 41 77 129 304 1,010 1,436 1,513 1,601 1,597 1,718 1,762 1,701 1,755 1,701

30-39 14 17 28 51 97 178 417 1,563 2,210 2,258 2,432 2,562 2,892 2,913 3,051 3,079 3,076

40-49 * * 16 28 74 154 349 1,424 2,185 2,228 2,481 2,703 3,130 3,394 3,484 3,908 3,892

50-59 * * * 16 28 84 255 1,076 1,564 1,658 1,774 1,973 2,262 2,602 2,807 3,037 3,366

60-64 . . . * * 13 63 279 480 498 559 658 735 837 933 1,063 1,189

65-69 . . . . . * 16 123 207 214 268 303 407 463 564 702 743

70-79 . . . . . * * 17 57 52 83 87 148 132 162 217 268

80-84 . . . . . . . . . . * * . * * * *

85+ . . . . . . . . . . * * . * . . *

Unknown . . . . . . . . . * . . . . . . .



0-17 * * * 12 24 41 77 289 415 366 367 397 410 383 336 436 463

18-44 30 41 62 107 210 394 922 3,323 4,811 4,922 5,368 5,590 6,187 6,422 6,447 6,758 6,599

45-64 * * 13 31 70 164 466 2,029 3,064 3,233 3,479 3,903 4,550 5,086 5,529 6,084 6,625

65-74 . . . . . * 18 136 254 258 345 376 537 575 705 885 971

75+ . . . . . . * * * * * 16 18 26 23 37 43

Unknown . . . . . . . . . * . . . . . . .



Male 24 25 43 72 165 336 776 3,355 5,229 5,332 5,799 6,142 6,956 7,460 7,887 8,494 8,667

Female 16 27 42 78 139 267 708 2,425 3,324 3,454 3,769 4,140 4,746 5,032 5,153 5,706 6,034

Unknown . . . . . . . * * * . . . . . . .



White 21 29 52 90 178 370 946 3,955 6,063 6,095 6,647 7,066 7,940 8,249 8,486 9,206 9,363

African American 18 22 29 55 118 213 478 1,516 2,046 2,272 2,409 2,738 3,121 3,520 3,758 4,110 4,402

Native American * . * * * * 13 69 92 99 93 110 129 127 143 195 164

Asian . * * * * 13 43 224 317 307 403 358 501 578 633 642 717

Other/Unknown . . . . * . * 17 36 15 16 * 11 18 20 47 55



†Hispanic * * * * 15 47 113 491 751 790 930 960 1,089 1,116 1,229 1,518 1,606

†Non-Hispanic 38 49 84 142 289 556 1,371 5,290 7,803 7,998 8,638 9,322 10,613 11,376 11,811 12,682 13,095



Diabetes * * * * 15 56 205 1,126 1,748 1,934 2,124 2,507 2,994 3,350 3,598 4,058 4,408

Hypertension * 16 18 23 55 115 272 1,013 1,605 1,617 1,920 2,079 2,426 2,649 2,824 2,833 2,969

Glomerulonephritis 17 24 39 72 126 222 511 1,859 2,541 2,636 2,788 2,836 3,151 3,203 3,393 3,722 3,648

Other cause/unknown 13 11 26 50 108 210 496 1,783 2,660 2,601 2,736 2,860 3,131 3,290 3,225 3,587 3,676



Listed for first transplant 24 35 46 92 151 373 1,051 4,467 6,877 7,117 7,784 8,387 9,650 10,369 10,874 11,843 12,323

Listed for subsequent transplant 16 17 39 58 153 230 433 1,314 1,677 1,671 1,784 1,895 2,052 2,123 2,166 2,357 2,378



Active at Listing . . . . . . . . . . . . . . . . 13,979

Inactive at Listing . . . . . . . . . . . . . . . . 446

Unknown 40 52 85 150 304 603 1,484 5,781 8,554 8,788 9,568 10,282 11,702 12,492 13,040 14,200 276



Blood type A * * 21 29 60 117 359 1,757 2,967 3,146 3,392 3,597 4,078 4,386 4,515 4,874 5,024

Blood type B * * 13 24 53 106 240 819 1,142 1,171 1,304 1,398 1,534 1,675 1,794 2,007 2,025

Blood type AB . . * * * 12 32 158 313 308 371 417 477 497 526 562 565

Blood type O 28 35 49 94 185 367 851 3,045 4,132 4,163 4,501 4,869 5,612 5,934 6,204 6,757 7,087

Unknown type . . . . . * * * . . . * * . * . .



PRA <10% * * 15 34 68 206 633 3,354 5,729 6,003 6,614 7,433 8,593 9,302 9,888 10,460 10,791

10% or greater 35 46 70 116 236 383 817 2,109 2,334 2,148 2,118 2,147 2,466 2,488 2,491 2,661 2,623

Unknown . . . . . 14 34 318 491 637 836 702 643 702 661 1,079 1,287



All 40 52 85 150 304 603 1,484 5,781 8,554 8,788 9,568 10,282 11,702 12,492 13,040 14,200 14,701

Table E.1

ESRD-certified patients added to the kidney or simultaneous kidney-pancreas waiting list

by age, gender, race, ethnicity, primary diagnosis, transplant number, blood type, & PRA



1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009

<1 12 14 12 11 12 19 17 20 26 31 38 28 32

1-4 36 40 40 41 49 40 52 65 64 56 83 64 91

5-9 78 57 54 62 90 90 69 100 86 107 99 125 90

10-17 287 288 329 301 339 355 435 468 463 494 474 469 446

18-29 1,777 1,712 1,847 1,722 1,782 1,856 1,912 2,005 2,046 2,061 2,074 2,159 2,143

30-39 3,120 3,173 3,341 3,331 3,278 3,499 3,544 3,627 3,744 3,755 3,696 3,682 3,648

40-49 3,986 4,208 4,418 4,734 4,699 5,000 5,059 5,376 5,714 5,793 6,063 5,797 5,976

50-59 3,631 4,117 4,546 5,048 5,189 5,669 6,022 6,576 6,971 7,637 7,671 7,630 7,707

60-64 1,316 1,490 1,614 1,875 2,042 2,179 2,361 2,727 2,901 3,224 3,548 3,755 3,859

65-69 825 941 1,116 1,292 1,349 1,485 1,722 1,999 2,089 2,416 2,511 2,629 2,779

70-79 309 378 495 633 656 783 918 1,041 1,237 1,419 1,477 1,528 1,625

80-84 * * * 18 22 21 29 35 51 61 51 64 83

85+ * * * * * * . * * 13 * * 14

Unknown . . . . . . . . * * * . *



0-17 413 399 435 415 490 504 573 653 639 688 694 686 659

18-44 6,804 6,955 7,295 7,191 7,260 7,623 7,757 8,045 8,422 8,464 8,542 8,403 8,474

45-64 7,026 7,745 8,471 9,519 9,730 10,580 11,141 12,266 12,954 14,006 14,510 14,620 14,859

65-74 1,079 1,247 1,510 1,808 1,851 2,108 2,448 2,790 3,022 3,475 3,611 3,765 4,007

75+ 59 83 112 139 177 182 221 290 359 434 435 465 494

Unknown . . . . . . . . * * * . *



Male 9,049 9,856 10,568 11,164 11,426 12,385 13,141 14,466 15,392 16,515 16,785 16,991 17,204

Female 6,332 6,573 7,255 7,908 8,082 8,612 8,999 9,578 10,005 10,553 11,008 10,948 11,290

Unknown . . . . . . . . . . . . .



White 9,807 10,399 11,325 11,900 11,928 12,908 13,574 14,557 15,419 16,489 16,584 16,734 17,055

African American 4,505 4,903 5,225 5,705 5,996 6,318 6,688 7,188 7,576 8,207 8,750 8,762 8,922

Native American 150 190 196 217 249 262 245 260 309 340 349 355 346

Asian 828 824 944 1,064 1,110 1,225 1,261 1,502 1,543 1,688 1,887 1,908 1,962

Other/Unknown 91 113 133 186 225 284 372 537 550 344 223 180 209



†Hispanic 1,981 2,040 2,450 2,691 2,895 3,197 3,651 3,935 4,154 4,545 4,735 4,857 5,103

†Non-Hispanic 13,400 14,389 15,373 16,381 16,613 17,800 18,489 20,109 21,243 22,523 23,058 23,082 23,391



Diabetes 4,693 5,127 5,699 6,298 6,376 7,088 7,414 8,249 8,601 9,351 9,721 9,951 10,205

Hypertension 2,962 3,194 3,526 3,947 4,074 4,149 4,551 4,983 5,167 5,532 5,751 5,896 6,060

Glomerulonephritis 3,858 4,106 4,241 4,210 4,325 4,654 4,659 4,955 5,214 5,329 5,213 5,003 4,978

Other cause/unknown 3,868 4,002 4,357 4,617 4,733 5,106 5,516 5,857 6,415 6,856 7,108 7,089 7,251



Listed for first transplant 13,082 13,949 15,074 16,242 16,391 17,572 18,708 20,194 21,307 22,765 23,438 23,583 24,162

Listed for subsequent transplant 2,299 2,480 2,749 2,830 3,117 3,425 3,432 3,850 4,090 4,303 4,355 4,356 4,332



Active at Listing 15,125 16,159 17,412 18,615 19,094 20,533 21,559 21,590 21,421 21,375 21,129 20,546 20,647

Inactive at Listing 251 269 348 393 335 398 504 2,370 3,906 5,606 6,558 7,303 7,753

Unknown * * 63 64 79 66 77 84 70 87 106 90 94



Blood type A 5,221 5,523 6,165 6,342 6,473 6,906 7,328 7,928 8,397 9,060 9,084 9,109 9,325

Blood type B 2,163 2,380 2,509 2,741 2,797 3,045 3,233 3,433 3,637 3,830 3,998 4,163 4,186

Blood type AB 597 652 714 741 746 817 835 907 1,031 1,088 1,102 1,089 1,128

Blood type O 7,400 7,874 8,435 9,248 9,492 10,229 10,744 11,776 12,332 13,090 13,609 13,578 13,855

Unknown type . . . . . . . . . . . . .



PRA <10% 11,358 12,141 13,062 13,844 14,226 15,137 15,688 16,966 17,897 18,623 18,882 18,282 13,586

10% or greater 2,583 2,915 3,408 3,678 4,040 4,604 5,120 5,858 6,355 7,253 7,661 7,599 5,229

Unknown 1,440 1,373 1,353 1,550 1,242 1,256 1,332 1,220 1,145 1,192 1,250 2,058 9,679



All 15,381 16,429 17,823 19,072 19,508 20,997 22,140 24,044 25,397 27,068 27,793 27,939 28,494

Table E.2

Median wait time among ESRD-certified patients (kidney-alone transplant)

by year of listing, age, gender, race, ethnicity, primary diagnosis, blood type, & PRA



1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

0-17 237 245 228 277 302 306 184 179 234 245 243 261 245 250 230 281 211 195 130 160 177

18-44 245 288 312 327 393 418 448 470 550 564 606 672 772 849 827 832 866 869 931 1,028 .

45-64 239 308 314 352 408 468 519 563 626 703 756 841 964 980 985 988 1,026 1,042 1,099 1,093 .

65-74 247 286 293 250 367 445 457 586 655 719 770 780 948 993 898 975 883 1,083 1,044 . .

75+ 85 289 276 354 388 937 549 1,009 742 529 671 1,101 1,281 867 795 818 1,194 994 989 . .

. . . . . . . . . . . . . . . . . . . . .

All 18 and older 242 296 313 331 397 444 480 515 597 633 693 772 887 930 918 929 960 987 1,038 . .

. . . . . . . . . . . . . . . . . . . . .

Male 225 283 296 317 383 417 442 471 548 581 649 711 824 860 863 859 856 908 928 1,086 .

Female 270 313 331 347 410 464 529 544 614 655 688 777 887 933 904 937 1,012 999 1,075 1,093 .

. . . . . . . . . . . . . . . . . . . . .

White 206 244 249 250 304 319 360 385 427 449 480 518 626 664 671 699 627 569 605 701 .

African American 372 424 465 542 630 676 786 851 950 1,058 1,152 1,225 1,287 1,326 1,324 1,225 1,319 1,359 1,402 . .

Native American 293 582 324 429 526 578 694 765 902 1,127 793 1,139 1,206 1,256 1,067 1,166 1,327 1,352 1,231 . .

Asian 259 321 372 473 462 585 929 855 1,011 988 942 1,103 1,349 1,287 1,303 1,225 1,230 1,271 . . .

Other 243 336 345 423 457 512 581 717 789 1,003 1,217 1,504 1,383 1,256 1,308 1,347 1,268 1,273 1,257 . .

. . . . . . . . . . . . . . . . . . . . .

†Hispanic 241 291 306 324 389 429 463 491 561 591 643 703 819 861 847 838 858 889 935 1,058 .

†Non-Hispanic 258 327 333 395 451 485 518 546 696 774 814 906 1,029 1,044 1,103 1,211 1,237 1,243 1,194 . .

. . . . . . . . . . . . . . . . . . . . .

Diabetes 220 253 267 283 344 375 444 475 567 619 736 972 1,161 1,212 1,209 1,214 1,294 1,391 1,380 . .

Hypertension 285 358 368 427 494 558 567 651 730 872 881 964 1,081 1,065 1,131 1,105 1,095 1,133 1,150 . .

Glomerulonephritis 264 306 320 327 391 455 481 506 575 579 604 579 692 731 699 692 688 683 680 792 .

Other cause 252 285 300 326 374 390 425 414 472 509 534 542 576 637 618 598 586 592 627 692 .

. . . . . . . . . . . . . . . . . . . . .

Blood type A 147 197 190 204 262 294 336 350 367 406 455 479 581 613 607 609 620 606 678 776 .

Blood type B 356 404 489 548 678 739 849 854 927 949 1,062 1,144 1,327 1,250 1,277 1,225 1,192 1,246 1,395 . .

Blood type AB 109 99 108 122 131 171 181 204 183 216 264 275 348 378 396 421 438 395 418 538 516

Blood type O 323 384 408 439 492 539 585 620 740 780 854 946 1,073 1,096 1,107 1,067 1,117 1,214 1,216 . .

. . . . . . . . . . . . . . . . . . . . .

PRA <10% 203 263 267 289 369 388 418 436 498 522 581 645 754 795 810 814 820 842 867 1,044 .

10% or greater 441 517 613 696 731 1,009 1,121 1,119 1,106 1,333 1,428 1,478 1,646 1,714 1,614 1,550 1,653 1,551 1,407 . .

. . . . . . . . . . . . . . . . . . . . .

Listed for first transplant 209 266 278 303 370 402 446 471 552 586 641 720 831 876 875 877 904 934 964 1,091 .

528

Listed for subsequent transplant 568 567 631 763 891 806 943 851 957 963 976 1,067 1,089 1,004 1,078 934 1,128 1,162 . .

. . . . . . . . . . . . . . . . . . . . .

All 242 295 308 329 394 437 468 499 577 614 661 739 846 889 883 889 906 942 981 1,091 .

Table E.2

Median wait time among ESRD-certified patients (kidney-alone transplant)

by year of listing, age, gender, race, ethnicity, primary diagnosis, blood type, & PRA



2009

0-17 138

18-44 .

45-64 .

65-74 .

75+ .

.

All 18 and older .

.

Male .

Female .

.

White .

African American .

Native American .

Asian .

Other .

.

†Hispanic .

†Non-Hispanic .

.

Diabetes .

Hypertension .

Glomerulonephritis .

Other cause .

.

Blood type A .

Blood type B .

Blood type AB .

Blood type O .

.

PRA <10% .

10% or greater .

.

Listed for first transplant .

Listed for subsequent transplant .

.

All .

Table E.3

Total ESRD-certified patients wait-listed for a kidney (as of December 31 of the year)

by age, gender, race, ethnicity, primary diagnosis, transplant number, blood type, PRA, & time on the list



1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996

<1 . . . . . . * * * * * * * 11 * * *

1-4 * * . . * * * 22 15 23 19 24 27 21 18 31 37

5-9 * * * * * 13 23 65 65 53 47 54 75 62 56 64 75

10-17 * * 13 21 31 56 105 227 262 268 281 314 350 357 269 294 324

18-29 49 69 84 116 185 305 549 1,214 1,457 1,657 1,820 1,948 2,179 2,385 2,561 2,621 2,790

30-39 38 57 91 140 228 390 784 1,849 2,081 2,483 2,764 3,116 3,666 4,075 4,476 4,870 5,262

40-49 12 22 40 70 154 314 649 1,622 1,995 2,421 2,855 3,295 4,078 4,696 5,273 6,184 6,851

50-59 * * 15 33 61 147 408 1,154 1,405 1,707 1,918 2,322 2,895 3,575 4,201 4,893 5,789

60-64 * * * * * 20 84 284 360 484 586 683 840 1,031 1,321 1,622 1,923

65-69 . . . . * * 23 127 163 215 275 319 434 564 740 1,001 1,189

70-79 . . . . . * * 16 31 50 77 111 164 204 222 287 405

80-84 . . . . . . . . * . * * . * * * *

85+ . . . . . . . . . . * * . * * . .

Unknown . . . . . . . . . * . . . . . . .

. . . . . . . . . . . . . . . . .

0-17 11 * 17 26 42 74 139 316 351 351 353 397 457 451 347 394 439

18-44 95 139 194 292 500 866 1,695 3,933 4,633 5,415 6,108 6,824 7,945 8,896 9,650 10,486 11,309

45-64 * 19 37 70 136 310 779 2,190 2,665 3,337 3,835 4,540 5,713 6,866 8,182 9,704 11,306

65-74 . . . . * * 26 137 188 258 345 412 580 743 932 1,245 1,522

75+ . . . . . . * * * * * 22 18 31 39 53 82

Unknown . . . . . . . . . * . . . . . . .

. . . . . . . . . . . . . . . . .

Male 63 87 127 195 352 670 1,390 3,668 4,451 5,361 6,134 7,002 8,492 9,780 11,047 12,520 14,108

Female 52 79 121 193 328 587 1,250 2,913 3,393 4,008 4,517 5,193 6,221 7,207 8,103 9,362 10,550

Unknown . . . . . . . * . . . . . . . . .

. . . . . . . . . . . . . . . . .

White 69 97 147 231 397 747 1,622 4,233 5,041 5,894 6,593 7,377 8,820 9,834 10,965 12,281 13,585

African American 43 65 94 145 263 469 926 2,022 2,390 2,971 3,425 4,120 5,040 6,113 6,942 8,057 9,249

Native American * * * * * 14 25 80 94 111 137 151 185 195 205 294 321

Asian * * * * 12 25 62 236 313 387 490 534 653 828 1,006 1,188 1,411

Other/Unknown . . . . * * * 11 * * * 13 15 17 32 62 92

. . . . . . . . . . . . . . . . .

†Hispanic * * * 16 30 75 180 541 724 885 1,081 1,223 1,473 1,683 1,956 2,422 2,851

†Non-Hispanic 111 159 240 372 650 1,182 2,460 6,041 7,120 8,484 9,570 10,972 13,240 15,304 17,194 19,460 21,807

. . . . . . . . . . . . . . . . .

Diabetes * * * * 23 77 274 1,042 1,291 1,612 1,894 2,359 3,127 3,626 4,194 5,053 6,008

Hypertension 17 33 51 73 127 237 489 1,204 1,528 1,883 2,246 2,687 3,303 3,979 4,523 5,067 5,670

Glomerulonephritis 55 78 115 182 302 513 985 2,268 2,622 3,075 3,417 3,680 4,273 4,858 5,481 6,222 6,862

Other cause/unknown 42 53 78 124 228 430 892 2,068 2,403 2,799 3,094 3,469 4,010 4,524 4,952 5,540 6,118

. . . . . . . . . . . . . . . . .

Listed for first transplant 75 110 154 238 383 745 1,726 4,715 5,610 6,715 7,701 8,885 10,911 12,655 14,378 16,624 18,865

Listed for subsequent transplant 40 56 94 150 297 512 914 1,867 2,234 2,654 2,950 3,310 3,802 4,332 4,772 5,258 5,793

. . . . . . . . . . . . . . . . .

Blood type A 32 39 60 88 145 257 593 1,721 2,064 2,543 2,816 3,234 4,057 4,707 5,409 6,212 6,813

Blood type B 13 22 35 58 110 209 434 1,003 1,250 1,510 1,773 2,089 2,496 2,870 3,278 3,755 4,308

Blood type AB . . * * * 22 52 168 178 190 221 266 336 437 471 524 572

Blood type O 70 105 151 237 415 768 1,558 3,687 4,350 5,125 5,841 6,606 7,823 8,973 9,992 11,391 12,965

Unknown type . . . . . * * * * * . . * . . . .

. . . . . . . . . . . . . . . . .

PRA <10% 16 22 37 70 137 341 953 3,207 4,124 5,289 6,202 7,422 9,317 10,981 12,475 14,241 16,926

10% or greater 99 144 211 318 543 902 1,643 3,157 3,417 3,680 3,913 4,258 4,923 5,479 6,075 6,734 7,207

Unknown . . . . . 14 44 218 303 400 536 515 473 527 600 907 525

. . . . . . . . . . . . . . . . .

Listed for <1 year 40 52 83 144 298 595 1,421 4,506 4,911 5,440 6,057 6,695 8,048 8,824 9,325 10,240 10,759

1 - <2 years 27 39 52 83 143 289 575 1,065 1,770 2,248 2,468 2,912 3,537 4,344 5,053 5,554 6,504

2- <3 years 18 27 39 50 81 140 281 439 521 912 1,071 1,255 1,544 1,840 2,389 2,990 3,438

3 - <4 years 14 18 26 39 49 78 137 246 249 308 540 595 669 842 998 1,413 1,845

4 - <5 years * 14 18 25 38 48 75 119 162 178 200 349 379 419 530 630 885

5+ years * 16 30 47 71 107 151 207 231 283 315 389 536 718 855 1,055 1,227

. . . . . . . . . . . . . . . . .

Active . . . . . . . . . . . . . . . . 10,711

Inactive . . . . . . . . . . . . . . . . 293

None/Unknown 115 166 248 388 680 1,257 2,640 6,582 7,844 9,369 10,651 12,195 14,713 16,987 19,150 21,882 13,654

. . . . . . . . . . . . . . . . .

All 115 166 248 388 680 1,257 2,640 6,582 7,844 9,369 10,651 12,195 14,713 16,987 19,150 21,882 24,658

Table E.3

Total ESRD-certified patients wait-listed for a kidney (as of December 31 of the year)

by age, gender, race, ethnicity, primary diagnosis, transplant number, blood type, PRA, & time on the list



1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009

<1 * * * * * 12 * 14 17 14 25 22 23

1-4 27 30 32 25 37 28 32 46 46 41 56 57 64

5-9 86 59 61 69 80 75 65 74 67 79 78 94 77

10-17 317 341 320 344 398 426 441 480 451 410 429 446 415

18-29 2,993 3,071 3,229 3,192 3,302 3,466 3,624 3,712 3,758 3,858 4,033 4,136 4,256

30-39 5,666 5,942 6,343 6,741 7,002 7,474 7,945 8,009 8,318 8,515 8,689 8,848 8,878

40-49 7,474 8,188 8,859 9,646 10,323 11,227 12,005 12,420 13,025 13,592 14,410 14,799 15,463

50-59 6,717 7,744 8,843 10,213 11,530 12,898 14,277 15,309 16,531 17,720 18,646 19,577 20,608

60-64 2,309 2,751 3,132 3,774 4,381 5,045 5,713 6,219 6,681 7,380 8,373 9,186 10,058

65-69 1,447 1,725 2,049 2,462 2,971 3,454 4,002 4,449 4,901 5,383 6,047 6,615 7,292

70-79 535 694 931 1,224 1,514 1,857 2,316 2,611 2,973 3,403 3,770 4,119 4,586

80-84 11 11 17 30 51 60 81 95 119 148 152 164 220

85+ * * * * * * * * * 18 20 27 34

Unknown . . . . . . . . * * * . *

. . . . . . . . . . . . .

0-17 435 440 419 448 519 541 547 614 581 544 588 619 579

18-44 12,226 12,983 13,802 14,402 15,120 16,049 16,990 17,389 18,034 18,615 19,258 19,555 20,008

45-64 12,933 14,713 16,604 19,164 21,418 24,061 26,574 28,280 30,279 32,450 34,893 36,991 39,255

65-74 1,892 2,308 2,813 3,450 4,177 4,920 5,851 6,488 7,183 7,984 8,893 9,687 10,755

75+ 103 126 188 271 363 456 555 676 820 968 1,096 1,238 1,377

Unknown . . . . . . . . * * * . *

. . . . . . . . . . . . .

Male 15,754 17,622 19,512 21,732 23,933 26,513 29,113 31,007 33,222 35,429 37,790 39,937 42,354

Female 11,835 12,948 14,314 16,003 17,664 19,514 21,404 22,440 23,676 25,133 26,939 28,153 29,621

Unknown . . . . . . . . . . . . .

. . . . . . . . . . . . .

White 15,032 16,439 18,119 20,049 21,849 24,064 26,386 27,896 29,781 31,880 34,108 35,972 38,225

African American 10,382 11,656 12,921 14,404 15,954 17,539 19,153 20,156 21,320 22,705 24,357 25,611 26,940

Native American 335 396 406 469 546 632 681 680 738 773 831 875 876

Asian 1,689 1,857 2,089 2,423 2,730 3,119 3,468 3,767 4,019 4,280 4,614 4,929 5,269

Other/Unknown 151 222 291 390 518 673 829 948 1,040 924 819 703 665

. . . . . . . . . . . . .

†Hispanic 3,558 4,019 4,725 5,584 6,376 7,228 8,330 9,231 10,097 11,081 12,086 12,849 13,916

†Non-Hispanic 24,031 26,551 29,101 32,151 35,221 38,799 42,187 44,216 46,801 49,481 52,643 55,241 58,059

. . . . . . . . . . . . .

Diabetes 6,979 8,024 9,189 10,764 12,163 13,945 15,657 16,961 18,339 20,044 21,754 23,182 24,995

Hypertension 6,202 6,869 7,734 8,793 9,766 10,649 11,873 12,678 13,444 14,213 15,069 15,824 16,853

Glomerulonephritis 7,588 8,248 8,864 9,372 10,049 10,874 11,460 11,803 12,274 12,549 13,005 13,228 13,565

Other cause/unknown 6,820 7,429 8,039 8,806 9,619 10,559 11,527 12,005 12,841 13,756 14,901 15,856 16,562

. . . . . . . . . . . . .

Listed for first transplant 21,449 24,065 26,864 30,373 33,543 37,035 40,861 43,304 46,107 49,235 52,657 55,394 58,870

Listed for subsequent transplant 6,140 6,505 6,962 7,362 8,054 8,992 9,656 10,143 10,791 11,327 12,072 12,696 13,105

. . . . . . . . . . . . .

Blood type A 7,538 8,362 9,399 10,421 11,421 12,583 13,887 14,720 15,624 16,852 18,078 19,025 20,115

Blood type B 4,770 5,296 5,712 6,388 7,054 7,817 8,618 9,024 9,519 9,998 10,591 11,076 11,826

Blood type AB 656 760 816 980 1,086 1,228 1,356 1,426 1,572 1,670 1,819 1,929 2,092

Blood type O 14,625 16,152 17,899 19,946 22,036 24,399 26,656 28,277 30,183 32,042 34,241 36,060 37,942

Unknown type . . . . . . . . . . . . .

. . . . . . . . . . . . .

PRA <10% 19,586 21,960 24,399 27,270 29,735 32,440 35,209 36,600 38,333 40,051 42,258 44,500 50,323

10% or greater 7,645 8,388 9,310 10,402 11,818 13,558 15,285 16,830 18,551 20,499 22,461 23,582 21,643

Unknown 358 222 117 63 44 29 23 17 14 12 * * *

. . . . . . . . . . . . .

Listed for <1 year 11,545 12,464 13,645 14,825 15,299 16,407 17,348 18,556 19,481 20,790 21,600 21,476 22,338

1 - <2 years 7,059 7,578 8,280 9,273 10,389 11,057 11,961 12,327 13,396 13,961 15,352 16,468 16,658

2- <3 years 4,196 4,674 5,016 5,638 6,481 7,403 7,955 8,305 8,586 9,347 10,066 11,027 12,083

3 - <4 years 2,162 2,681 3,022 3,335 3,869 4,544 5,206 5,437 5,751 5,895 6,486 6,979 7,784

4 - <5 years 1,109 1,322 1,649 1,950 2,265 2,655 3,167 3,410 3,645 3,958 4,027 4,459 4,701

5+ years 1,518 1,851 2,214 2,714 3,294 3,961 4,880 5,412 6,039 6,611 7,198 7,681 8,411

. . . . . . . . . . . . .

Active 18,224 24,009 28,855 33,279 36,787 40,199 41,868 41,356 41,819 42,347 43,397 44,920 45,927

Inactive 640 926 1,243 1,799 2,763 4,200 7,293 11,051 14,257 17,563 20,770 22,708 25,699

None/Unknown 8,725 5,635 3,728 2,657 2,047 1,628 1,356 1,040 822 652 562 462 349

. . . . . . . . . . . . .

All 27,589 30,570 33,826 37,735 41,597 46,027 50,517 53,447 56,898 60,562 64,729 68,090 71,975

Table E.4

Percent of prevalent dialysis patients wait-listed for a kidney

by age, gender, race, ethnicity, & primary diagnosis



1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000

<1 . . . . . . 1.4 2.8 9.8 8.0 7.2 3.2 4.2 10.2 4.4 4.8 3.4 5.6 9.9 5.8 8.4

1-4 3.7 2.2 . . 1.3 4.4 9.1 20.4 16.1 21.6 19.4 20.8 23.8 18.5 13.6 21.3 23.7 24.3 26.4 31.1 22.1

5-9 1.8 1.9 3.0 2.5 4.8 7.3 12.5 35.2 35.3 25.0 22.0 27.8 38.6 30.4 24.1 29.0 32.9 33.9 25.6 25.5 27.5

10-17 1.2 0.7 1.4 2.3 3.7 6.3 12.2 25.0 28.3 29.5 29.2 32.3 33.4 34.2 27.5 28.2 30.2 29.3 32.0 31.8 30.9

18-29 1.0 1.3 1.5 2.0 3.0 4.9 8.8 18.9 21.1 22.4 23.7 24.7 26.0 27.5 28.6 29.0 30.0 31.6 31.3 32.8 32.3

30-39 0.6 0.7 1.0 1.5 2.2 3.6 6.8 15.1 16.0 17.3 18.2 19.1 20.9 21.8 22.7 24.1 25.2 26.5 27.3 28.5 29.7

40-49 0.2 0.3 0.4 0.6 1.3 2.4 4.8 11.1 12.3 13.3 14.1 14.6 16.4 17.4 17.9 19.2 19.8 20.6 21.2 22.0 23.1

50-59 0.0 0.1 0.1 0.2 0.3 0.8 2.1 5.7 6.4 7.2 7.5 8.3 9.4 10.7 11.4 12.5 13.6 14.5 15.4 16.4 17.7

60-64 0.0 0.0 0.0 0.0 0.1 0.2 0.7 2.1 2.5 3.1 3.3 3.6 4.1 4.9 5.8 6.7 7.5 8.3 9.3 10.3 11.8

65-69 . . . . 0.0 0.1 0.2 0.9 1.0 1.3 1.4 1.5 1.9 2.2 2.7 3.5 4.0 4.6 5.3 6.2 7.2

70-79 . . . . . 0.0 0.0 0.1 0.1 0.2 0.3 0.3 0.5 0.5 0.5 0.6 0.8 1.0 1.1 1.5 1.9

80-84 . . . . . . . . . . 0.0 0.0 . 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2

85+ . . . . . . . . . . 0.1 0.1 . 0.1 0.0 . . 0.0 0.1 0.0 0.1



0-17 1.3 0.9 1.5 2.1 3.5 5.9 11.2 24.7 27.1 26.8 25.8 28.5 31.2 30.6 24.1 26.2 28.3 28.1 29.1 28.8 27.9

18-44 0.6 0.8 1.0 1.4 2.3 3.7 7.0 15.3 16.7 17.8 18.6 19.4 21.0 22.2 22.8 23.9 24.7 25.9 26.6 27.6 28.4

45-64 0.0 0.1 0.1 0.2 0.4 0.8 2.0 5.2 5.9 6.8 7.2 7.8 8.9 9.9 10.8 12.0 12.9 13.8 14.5 15.5 16.9

65-74 . . . . 0.0 0.0 0.1 0.6 0.6 0.8 1.0 1.0 1.3 1.5 1.8 2.2 2.6 3.0 3.5 4.2 5.0

75+ . . . . . . 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.3 0.4 0.5



Male 0.2 0.3 0.3 0.5 0.8 1.4 2.7 6.5 7.2 7.9 8.2 8.5 9.3 9.9 10.3 11.0 11.6 12.0 12.5 13.2 14.0

Female 0.2 0.3 0.4 0.5 0.8 1.4 2.7 5.6 6.0 6.4 6.5 6.8 7.3 7.9 8.1 8.8 9.3 9.9 10.1 10.8 11.5



White 0.2 0.2 0.3 0.5 0.7 1.3 2.6 6.4 7.0 7.5 7.6 7.8 8.5 8.9 9.2 9.9 10.2 10.6 11.0 11.6 12.2

African American 0.3 0.3 0.4 0.6 0.9 1.5 2.7 5.4 5.7 6.3 6.6 7.1 7.8 8.6 9.0 9.7 10.4 10.9 11.5 12.2 13.1

Native American 0.3 0.3 0.4 0.6 0.9 1.6 2.5 6.7 6.9 7.1 7.8 7.7 8.1 7.7 7.3 9.6 9.7 9.4 10.3 9.9 10.8

Asian 0.6 0.7 0.7 0.8 1.0 1.6 3.5 10.9 12.4 12.8 14.0 12.7 13.2 14.1 14.9 15.6 16.7 18.4 18.5 19.4 20.7



†Hispanic 0.4 0.5 0.5 0.7 1.1 2.3 4.6 11.4 12.0 11.5 12.0 11.7 11.5 11.1 11.2 11.3 11.4 12.7 12.9 14.0 14.7

†Non-Hispanic 0.2 0.3 0.4 0.5 0.8 1.3 2.6 5.8 6.4 6.9 7.1 7.4 8.1 8.8 9.1 9.8 10.4 10.7 11.2 11.8 12.5



Diabetes 0.0 0.0 0.0 0.1 0.1 0.4 1.3 4.2 4.5 4.7 4.7 4.9 5.7 5.9 6.0 6.5 6.9 7.3 7.6 8.3 9.1

Hypertension 0.2 0.3 0.3 0.4 0.6 1.0 1.8 4.0 4.5 5.0 5.3 5.6 6.1 6.8 7.1 7.7 8.3 8.6 9.1 9.8 10.7

Glomerulonephritis 0.5 0.6 0.8 1.1 1.7 2.7 4.9 10.5 11.5 12.5 13.2 13.5 14.7 15.9 16.9 18.4 19.3 20.6 21.6 22.7 23.7

Other cause 0.2 0.2 0.3 0.4 0.7 1.4 2.9 6.5 7.4 8.4 9.0 9.7 10.8 11.7 12.4 13.1 13.8 14.7 15.1 15.7 16.5



All 0.2 0.3 0.4 0.5 0.8 1.4 2.7 6.1 6.6 7.2 7.4 7.7 8.4 8.9 9.3 10.0 10.5 11.0 11.4 12.1 12.8

Table E.4

Percent of prevalent dialysis patients wait-listed for a kidney

by age, gender, race, ethnicity, & primary diagnosis



2001 2002 2003 2004 2005 2006 2007 2008 2009

<1 3.5 11.2 8.0 10.2 13.3 10.5 17.7 13.9 9.1

1-4 33.6 23.7 27.0 37.5 31.4 33.9 37.0 34.6 40.8

5-9 32.3 30.1 29.0 31.6 30.1 33.8 36.3 43.4 37.4

10-17 34.2 34.8 35.3 37.9 36.9 36.1 37.4 38.6 37.0

18-29 33.3 35.1 36.9 37.2 36.9 36.7 37.1 37.1 37.4

30-39 30.5 32.1 33.7 33.9 34.5 34.6 34.8 34.7 34.0

40-49 24.0 25.4 26.4 26.5 27.3 27.6 28.7 28.7 29.0

50-59 18.7 19.9 20.9 21.3 21.6 22.1 22.3 22.6 22.9

60-64 13.1 14.3 15.3 16.0 16.4 17.1 18.1 18.6 18.8

65-69 8.3 9.4 10.5 11.4 12.1 12.8 13.6 14.2 14.9

70-79 2.2 2.7 3.2 3.6 4.0 4.5 4.9 5.2 5.7

80-84 0.3 0.3 0.3 0.4 0.5 0.6 0.6 0.6 0.8

85+ 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2



0-17 31.6 31.7 32.0 34.7 33.7 33.3 35.4 36.3 33.1

18-44 29.3 30.8 32.3 32.5 33.1 33.3 33.8 33.5 33.6

45-64 17.9 19.2 20.2 20.5 20.9 21.3 22.0 22.3 22.5

65-74 5.8 6.7 7.8 8.4 9.1 9.7 10.4 10.9 11.6

75+ 0.6 0.7 0.8 0.9 1.1 1.2 1.4 1.5 1.6



Male 14.6 15.5 16.3 16.7 17.1 17.5 17.9 18.1 18.4

Female 12.2 13.1 13.9 14.2 14.5 14.9 15.5 15.7 15.9



White 12.7 13.4 14.2 14.5 14.8 15.2 15.7 15.9 16.2

African American 13.9 14.8 15.5 15.9 16.3 16.7 17.3 17.5 17.7

Native American 11.9 13.3 13.9 13.5 14.2 14.5 15.1 15.4 14.9

Asian 21.7 23.2 24.4 25.1 25.2 25.2 25.6 25.7 25.7



†Hispanic 15.7 16.7 18.0 18.7 19.4 20.0 20.4 20.4 20.9

†Non-Hispanic 13.2 14.0 14.7 15.0 15.3 15.6 16.1 16.4 16.6



Diabetes 9.7 10.5 11.3 11.7 12.1 12.6 13.2 13.5 13.9

Hypertension 11.4 11.9 12.7 13.1 13.5 13.8 14.1 14.2 14.4

Glomerulonephritis 25.0 26.7 28.1 28.6 29.4 30.0 31.0 31.2 31.6

Other cause 17.5 18.6 19.8 20.0 20.3 20.6 21.4 21.9 22.0



All 13.5 14.4 15.2 15.5 15.9 16.3 16.8 17.0 17.3

Table E.5

Percent of patients either wait-listed or receiving a deceased-donor kidney within one year of ESRD initiation

by age, gender, race, ethnicity, & primary diagnosis



1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000

<1 54.9 30.6 42.9 37.9 26.9 30.5 39.7 32.1 33.5 34.5 27.6 35.1 25.3 23.4 17.6 18.3 22.8 25.7 38.6 24.8 18.3

1-4 31.3 20.8 50.8 49.4 49.0 58.3 48.6 68.5 86.8 59.0 68.0 35.3 65.4 46.4 59.5 58.1 53.8 50.9 48.6 44.5 39.7

5-9 55.7 52.5 49.7 53.1 51.4 57.3 73.8 69.5 73.4 60.7 61.3 74.1 58.2 60.1 52.2 65.8 62.3 63.0 43.2 58.2 49.7

10-17 39.9 35.6 39.2 41.4 41.0 47.8 52.1 58.7 64.5 52.8 56.4 54.0 54.5 50.5 50.8 52.4 51.1 52.9 53.8 54.0 45.9

18-29 27.6 27.4 28.0 28.5 28.9 31.8 37.1 42.9 41.9 41.9 37.4 39.4 37.4 36.6 37.2 34.2 34.6 34.1 32.0 32.4 29.7

30-39 18.9 21.3 22.5 23.0 22.4 25.8 31.0 35.1 34.7 33.4 33.0 31.5 32.4 31.2 29.6 30.5 29.4 28.3 29.3 27.7 26.8

40-49 11.2 12.7 12.1 13.5 13.3 15.9 20.6 26.4 26.9 25.4 24.7 24.4 24.9 23.9 23.3 24.3 23.1 21.7 21.6 21.4 20.3

50-59 4.2 3.9 4.0 4.3 4.9 5.7 8.6 12.3 12.8 12.1 12.6 12.9 13.2 13.7 14.0 13.5 13.6 14.6 14.4 14.0 13.8

60-64 0.4 0.8 0.6 1.1 1.2 1.8 3.0 4.5 4.8 4.5 5.2 5.6 5.5 6.2 6.1 7.6 7.6 8.1 8.1 8.5 9.0

65-69 0.3 . 0.1 0.2 0.4 0.6 0.7 1.4 1.3 1.7 1.9 2.0 2.2 2.8 2.9 3.9 3.5 3.8 4.3 4.6 4.7

70-79 . 0.0 0.0 0.1 0.2 0.1 0.1 0.3 0.3 0.4 0.4 0.4 0.5 0.4 0.4 0.6 0.6 0.8 0.9 1.1 1.2

80-84 . . . . 0.1 . 0.3 0.1 . . 0.1 . 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1

85+ . . . . . 0.3 . . . 0.3 0.2 0.2 . . . . . . 0.1 0.1 0.0



0-17 42.5 37.8 42.0 43.3 41.8 48.3 54.4 58.9 63.6 52.5 54.8 52.8 52.3 48.3 48.3 51.1 50.1 51.0 49.9 51.5 42.6

18-44 20.2 21.7 22.5 22.8 22.9 25.7 30.9 35.7 35.4 34.2 32.6 32.4 31.8 30.8 29.9 29.6 29.1 28.1 27.5 26.8 25.5

45-64 4.1 4.1 3.8 4.5 4.6 5.7 8.3 11.6 12.0 11.5 11.6 11.8 12.5 12.8 12.9 13.5 13.2 13.5 13.6 13.5 13.4

65-74 0.2 0.0 0.1 0.2 0.3 0.3 0.5 1.0 0.9 1.2 1.2 1.3 1.5 1.7 1.8 2.4 2.2 2.5 2.7 3.1 3.2

75+ . . . . 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.2 0.1 0.2 0.2 0.3 0.3



Male 9.4 10.2 9.7 9.5 9.5 10.6 12.9 15.8 15.2 14.1 13.8 13.1 13.0 12.9 12.4 13.0 12.1 11.6 11.4 11.2 10.7

Female 6.8 6.5 6.8 6.3 6.5 7.4 9.6 10.8 11.5 10.5 9.7 9.7 9.7 9.2 9.1 9.3 8.9 8.6 8.7 8.6 8.2



White 9.5 10.2 9.8 9.6 9.5 10.7 13.2 15.4 14.9 14.2 13.3 12.8 12.6 12.2 11.5 12.2 11.2 11.0 10.9 10.4 9.7

African American 4.9 4.8 4.8 4.4 5.1 5.4 7.0 8.7 9.5 8.3 8.3 8.2 8.5 8.6 8.8 9.2 8.9 8.1 8.0 8.3 8.4

Native American 9.4 4.2 3.7 8.3 5.5 8.3 10.8 9.5 12.2 8.6 9.9 10.5 9.2 8.6 11.0 10.8 9.8 9.4 8.5 8.5 8.0

Asian 20.5 12.1 16.4 9.6 10.2 12.4 13.8 21.8 23.2 20.8 19.6 17.7 17.8 17.8 16.6 14.0 17.1 15.8 16.2 17.2 17.1



†Hispanic 10.9 11.7 13.6 13.6 12.6 15.2 16.7 21.3 20.5 18.2 16.4 15.6 12.7 11.9 10.8 10.4 8.8 9.3 9.9 9.4 9.2

†Non-Hispanic 8.2 8.5 8.3 7.9 8.0 8.9 11.2 13.1 13.0 12.1 11.6 11.2 11.3 11.1 10.8 11.3 10.8 10.3 10.1 10.0 9.6



Diabetes 9.4 9.4 8.3 7.4 8.0 8.8 10.3 11.6 10.7 10.4 9.1 9.0 9.2 8.6 8.8 9.0 8.6 8.2 8.1 8.2 7.9

Hypertension 5.3 4.4 4.2 3.7 4.1 4.4 5.9 7.8 8.1 7.1 7.5 7.0 7.3 7.1 6.5 7.3 6.9 6.2 6.4 6.6 6.7

Glomerulonephritis 13.8 13.9 13.8 14.6 12.8 15.5 19.3 23.2 23.8 22.5 22.0 21.7 22.7 22.4 21.8 22.3 20.8 21.6 21.6 21.1 20.3

Other cause 7.2 8.0 8.7 8.3 9.2 10.4 13.5 16.1 17.1 16.9 17.1 16.9 15.9 16.7 15.9 15.2 14.6 14.8 14.8 13.8 12.9



All 8.3 8.5 8.4 8.0 8.1 9.1 11.4 13.5 13.4 12.4 11.9 11.5 11.4 11.2 10.8 11.2 10.6 10.2 10.1 10.0 9.6

Table E.5

Percent of patients either wait-listed or receiving a deceased-donor kidney within one year of ESRD initiation

by age, gender, race, ethnicity, & primary diagnosis



2001 2002 2003 2004 2005 2006 2007 2008

<1 14.8 25.7 24.7 24.7 22.9 35.5 28.9 24.4

1-4 53.6 43.6 65.8 53.0 56.4 55.1 46.2 59.2

5-9 55.1 42.0 53.7 50.6 61.4 65.5 58.6 67.9

10-17 45.7 47.8 53.1 47.7 55.2 59.5 58.9 57.0

18-29 29.4 29.1 27.4 29.7 26.7 29.2 28.3 29.4

30-39 25.3 26.5 24.9 25.7 25.7 27.2 25.9 25.9

40-49 20.0 18.6 19.3 19.5 20.0 20.7 21.0 20.5

50-59 13.6 13.8 14.1 14.7 15.1 16.0 16.3 15.7

60-64 8.5 9.2 10.0 10.4 11.4 12.6 12.7 13.4

65-69 5.1 5.9 6.2 7.4 8.0 9.0 9.2 10.0

70-79 1.2 1.3 1.4 2.1 2.4 2.7 2.7 3.3

80-84 0.1 0.1 0.2 0.2 0.2 0.2 0.4 0.3

85+ . . 0.0 . 0.1 0.1 . 0.1



0-17 44.4 44.6 51.2 45.8 52.6 56.7 54.1 53.9

18-44 24.7 24.3 23.7 24.9 24.5 25.8 25.2 25.4

45-64 13.0 13.2 13.6 14.0 14.6 15.6 15.8 15.6

65-74 3.4 3.9 4.2 5.3 5.9 6.6 6.6 7.4

75+ 0.3 0.3 0.3 0.5 0.6 0.6 0.8 0.9



Male 10.1 10.5 10.7 11.4 11.7 12.6 12.5 12.6

Female 8.3 8.1 8.4 8.8 9.3 10.1 10.3 10.6



White 9.4 9.5 9.8 10.0 10.6 11.3 11.2 11.5

African American 8.0 8.2 8.3 9.2 9.4 10.3 10.5 10.6

Native American 7.0 9.3 7.5 9.1 9.7 10.4 11.3 11.8

Asian 18.0 16.4 17.9 19.5 17.6 20.7 22.1 22.0



†Hispanic 9.6 10.1 10.6 10.7 11.6 12.8 12.9 13.2

†Non-Hispanic 9.2 9.2 9.5 10.1 10.5 11.2 11.3 11.5



Diabetes 7.6 8.0 8.0 8.6 9.0 9.7 9.9 10.0

Hypertension 6.1 6.1 6.5 7.0 7.3 8.1 8.1 8.4

Glomerulonephritis 20.2 21.1 21.7 22.9 23.6 26.7 25.8 27.5

Other cause 13.4 12.5 13.5 13.7 14.4 14.9 15.4 15.2



All 9.3 9.4 9.6 10.2 10.6 11.5 11.5 11.7

Table E.5(2)

Percent of patients wait-listed or receiving a deceased- or living-donor kidney within one year of ESRD initiation

by age, gender, race, ethnicity, & primary diagnosis



1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000

<1 46.1 39.5 37.7 40.0 36.5 35.0 40.1 47.2 39.9 37.7 36.9 44.7 28.2 38.4 28.4 38.0 33.2 36.0 46.4 34.0 31.5

1-4 48.0 35.9 60.6 55.1 47.2 62.5 65.4 70.7 82.0 69.7 73.9 63.7 76.1 63.9 59.8 56.6 74.9 71.9 58.8 69.5 64.9

5-9 63.9 53.6 59.4 62.8 61.4 66.1 76.7 74.3 74.2 71.8 70.6 78.8 74.4 72.5 56.8 75.3 70.4 70.0 60.5 67.2 60.3

10-17 46.2 42.7 46.5 52.6 54.0 56.2 61.6 66.5 72.0 62.3 64.9 65.3 62.2 60.4 61.2 63.4 61.9 63.2 64.9 64.6 59.5

18-29 34.8 35.6 38.2 37.1 36.9 41.0 45.4 50.0 49.2 49.0 45.7 47.0 45.9 46.4 45.5 44.3 44.8 44.0 43.6 44.3 42.4

30-39 23.6 27.7 28.1 28.7 28.5 32.3 37.7 40.7 39.1 38.1 38.4 37.5 38.0 36.9 36.1 37.4 35.6 35.8 37.3 35.7 35.8

40-49 14.5 15.7 15.7 16.7 17.1 20.8 26.1 29.5 29.5 28.4 28.2 27.9 28.7 28.1 27.2 28.7 28.0 26.9 27.1 27.8 27.3

50-59 4.8 5.0 5.5 5.7 6.5 7.8 11.0 14.2 14.2 13.7 14.2 14.6 15.3 16.1 16.2 16.4 16.4 18.2 18.1 18.1 18.0

60-64 0.4 1.0 0.9 1.3 1.5 2.3 4.0 4.9 5.2 5.1 5.7 6.4 6.5 7.1 7.4 8.9 9.1 9.9 10.2 10.5 11.4

65-69 0.3 0.0 0.1 0.3 0.5 0.6 1.0 1.6 1.4 1.8 2.1 2.2 2.5 3.1 3.4 4.5 4.2 4.5 5.1 5.7 6.0

70-79 . 0.0 0.0 0.1 0.2 0.2 0.2 0.3 0.3 0.4 0.4 0.4 0.5 0.5 0.5 0.7 0.7 0.9 1.0 1.3 1.4

80-84 . . . . 0.1 . 0.3 0.1 . . 0.1 . 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1

85+ 0.7 . . . . 0.3 0.4 . . 0.3 0.3 0.2 0.1 . . . . . 0.1 0.1 0.0



0-17 49.4 43.9 48.8 53.1 53.2 55.8 62.1 65.9 69.2 61.9 63.7 64.4 61.3 60.1 56.8 62.1 61.1 61.8 61.4 61.9 56.2

18-44 26.0 28.2 29.8 29.3 29.3 33.0 38.2 41.4 40.5 39.5 38.7 38.3 37.9 37.5 36.5 36.9 36.1 35.8 35.7 35.7 35.1

45-64 5.0 5.4 5.3 5.8 6.3 7.8 10.8 13.2 13.3 13.1 13.1 13.5 14.6 15.0 15.2 16.2 16.1 16.8 17.3 17.4 17.5

65-74 0.2 0.1 0.1 0.2 0.4 0.4 0.7 1.1 0.9 1.2 1.4 1.5 1.7 1.9 2.1 2.8 2.6 3.0 3.3 3.9 4.1

75+ 0.1 . . . 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.2 0.2 0.1 0.2 0.1 0.2 0.3 0.3 0.3



Male 12.8 14.2 14.3 13.3 13.6 15.0 17.6 19.2 18.3 17.3 17.0 16.4 16.3 16.4 15.6 16.6 15.7 15.4 15.4 15.3 15.1

Female 9.8 9.6 10.2 9.4 9.7 10.8 12.9 13.7 14.1 13.1 12.5 12.3 12.4 12.0 11.9 12.4 11.9 11.8 12.0 12.2 11.8



White 13.5 14.5 14.6 13.9 13.9 15.7 18.3 19.3 18.5 17.9 17.2 16.6 16.4 16.2 15.3 16.5 15.5 15.5 15.6 15.3 14.7

African American 5.8 6.2 6.8 5.8 6.8 6.8 8.5 10.2 10.6 9.3 9.4 9.4 9.8 10.1 10.3 11.0 10.5 9.7 9.8 10.1 10.4

Native American 12.6 10.5 7.3 12.5 10.4 14.8 13.8 13.5 15.4 11.8 12.5 13.2 11.6 10.5 14.0 13.8 12.4 11.4 11.0 10.7 11.5

Asian 24.4 17.7 20.2 14.4 12.9 17.0 19.9 24.3 25.1 23.6 22.2 20.2 20.7 21.0 19.6 17.3 20.3 19.4 19.7 20.6 21.5



†Hispanic 15.5 15.1 17.7 18.4 17.8 21.2 22.8 25.5 24.4 22.2 20.1 19.4 16.8 15.7 14.7 13.8 12.0 12.8 13.7 12.9 12.9

†Non-Hispanic 11.4 12.1 12.3 11.3 11.6 12.8 15.2 16.2 15.8 14.9 14.6 14.1 14.3 14.3 13.8 14.8 14.2 13.8 13.8 14.0 13.7



Diabetes 12.9 12.7 12.3 10.9 11.2 12.6 14.0 14.2 12.9 12.2 11.2 10.9 11.0 10.4 10.6 10.9 10.3 10.0 9.9 10.1 9.9

Hypertension 7.0 6.3 5.9 5.0 5.8 6.1 7.6 9.0 9.2 8.3 8.6 8.3 8.7 8.5 8.0 9.0 8.6 8.0 8.2 8.7 8.9

Glomerulonephritis 19.1 19.6 20.5 20.2 18.5 21.3 25.3 28.5 28.7 28.1 27.9 27.4 28.6 29.0 28.0 29.5 28.3 29.8 30.3 30.4 30.2

Other cause 10.1 11.4 12.7 11.9 13.4 15.1 18.5 20.2 20.8 21.2 21.5 21.8 21.2 22.2 21.1 20.9 20.3 20.9 21.4 21.0 20.3



All 11.5 12.1 12.4 11.5 11.8 13.1 15.5 16.7 16.3 15.4 14.9 14.5 14.5 14.4 13.8 14.6 13.9 13.7 13.8 13.9 13.6

Table E.5(2)

Percent of patients wait-listed or receiving a deceased- or living-donor kidney within one year of ESRD initiation

by age, gender, race, ethnicity, & primary diagnosis



2001 2002 2003 2004 2005 2006 2007 2008

<1 32.1 39.0 30.8 35.7 32.0 44.6 42.1 28.7

1-4 69.8 63.3 72.6 70.0 67.1 62.1 62.9 68.8

5-9 61.1 63.6 65.8 66.6 67.4 73.3 72.6 72.9

10-17 59.6 61.8 64.5 59.2 65.5 66.9 66.0 66.3

18-29 42.3 42.0 41.7 43.4 39.9 42.2 40.0 40.9

30-39 34.0 35.8 35.0 34.8 35.3 35.4 33.8 33.1

40-49 26.9 25.4 25.9 26.1 26.4 26.9 27.0 26.0

50-59 18.2 18.3 18.9 19.4 19.8 20.4 20.4 19.5

60-64 10.8 12.4 12.6 13.3 14.2 15.7 15.4 16.3

65-69 6.7 7.8 8.1 9.4 10.0 11.0 11.3 11.9

70-79 1.5 1.7 1.8 2.6 3.0 3.3 3.2 3.9

80-84 0.1 0.1 0.3 0.2 0.3 0.2 0.4 0.4

85+ . . 0.1 0.0 0.1 0.1 0.0 0.1



0-17 57.0 59.7 61.5 58.0 61.9 64.3 63.2 62.4

18-44 34.2 34.2 33.9 34.5 34.0 34.7 33.4 33.1

45-64 17.3 17.7 18.0 18.5 19.0 19.9 19.8 19.4

65-74 4.4 5.1 5.6 6.7 7.3 8.1 8.1 8.9

75+ 0.4 0.4 0.4 0.6 0.7 0.7 0.9 1.0



Male 14.6 14.9 15.1 15.8 16.0 16.7 16.3 16.1

Female 11.8 11.9 12.1 12.5 12.8 13.4 13.5 13.7



White 14.5 14.6 14.8 15.0 15.5 15.8 15.3 15.3

African American 9.8 10.2 10.3 11.0 11.2 12.0 12.1 11.9

Native American 9.6 11.5 9.8 11.5 12.1 15.0 16.2 15.1

Asian 21.8 20.8 22.1 23.4 21.2 26.5 29.8 29.3



†Hispanic 13.3 13.9 14.3 14.0 15.0 16.0 15.9 16.0

†Non-Hispanic 13.3 13.4 13.6 14.3 14.5 15.1 14.9 14.9



Diabetes 9.7 10.1 9.9 10.6 11.0 11.6 11.6 11.6

Hypertension 8.1 8.3 8.8 9.2 9.4 10.2 10.0 10.1

Glomerulonephritis 30.2 31.2 32.5 33.7 33.8 36.8 36.0 37.4

Other cause 21.0 20.3 21.4 21.2 21.6 21.7 21.8 21.4



All 13.3 13.5 13.8 14.3 14.6 15.3 15.1 15.0

Table E.6

Renal transplants: by donor type





Living donor relation

Living Distantly Spouse/ Paired Unrelated Non-directed Living-Deceased

Deceased (Total) Related related life partner exchange directed donation exchange Unk. Unk. Total

1980 2,580 915 . . . . . . . 915 293 3,788

1981 2,870 1,137 . . . . . . . 1,137 226 4,233

1982 3,400 1,551 . . . . . . . 1,551 162 5,113

1983 3,965 1,711 . . . . . . . 1,711 200 5,876

1984 4,610 1,930 . . . . . . . 1,930 202 6,742

1985 4,944 2,325 . . . . . . . 2,325 239 7,508

1986 5,778 2,856 . . . . . . . 2,856 254 8,888

1987 6,061 2,691 . . . . . . . 2,691 190 8,942

1988 7,276 1,838 1,648 37 40 . 30 * . 82 131 9,245

1989 7,104 1,919 1,731 31 54 . 31 . . 72 128 9,151

1990 7,802 2,098 1,776 46 59 . 30 . . 187 141 10,041

1991 7,747 2,402 2,192 48 59 . 47 . . 56 126 10,275

1992 7,694 2,544 2,260 71 80 . 78 . . 55 173 10,411

1993 8,187 2,873 2,458 100 120 . 69 . . 126 116 11,176

1994 8,382 3,009 2,375 127 134 * 76 . . 296 116 11,507

1995 8,609 3,395 2,793 181 260 . 155 . . * 165 12,169

1996 8,584 3,687 2,840 214 363 . 223 . * 45 132 12,403

1997 8,620 3,940 3,001 233 381 . 274 . * 48 121 12,681

1998 9,005 4,422 3,158 296 547 . 362 * * 56 185 13,612

1999 8,977 4,728 3,289 348 577 . 476 * * 31 152 13,857

2000 9,035 5,497 3,618 411 669 * 774 20 * * 108 14,640

2001 9,116 6,042 3,884 468 716 * 926 28 * * 81 15,239

2002 9,443 6,236 3,848 494 721 * 1,108 54 * . 74 15,753

2003 9,529 6,473 3,848 478 732 19 1,309 75 * * 87 16,089

2004 10,236 6,649 3,831 510 803 34 1,383 80 * * 72 16,957

2005 10,811 6,570 3,697 506 832 27 1,426 69 11 * 77 17,458

2006 11,576 6,433 3,510 491 823 74 1,452 58 22 * 62 18,071

2007 11,450 6,043 3,181 491 798 111 1,286 79 91 * 28 17,521

2008 11,385 5,968 3,045 464 757 226 1,295 80 99 * 63 17,416

2009 11,291 6,388 3,146 502 836 277 1,377 119 127 * 57 17,736



Tot unrel Tot rel

2008 2,923 3,045

2009 3,242 3,146

% change 10.91345 3.316913

Table E.7

Renal transplants: recipients age <18

by age, gender, race, ethnicity, donor type, & number of transplants



1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001

<1 . * * * * * * 16 * * * 11 * * * * * * * 12 * *

1-4 19 28 47 63 75 82 78 104 102 92 91 98 101 119 79 86 110 120 91 115 93 126

5-9 67 77 83 79 100 126 114 127 114 135 135 153 111 133 122 141 141 126 137 130 106 134

10-14 143 125 160 188 232 206 220 217 222 210 185 197 195 199 221 237 221 215 232 255 207 228

15-17 131 165 151 185 182 196 214 204 237 200 222 180 177 213 250 256 238 230 214 253 222 239



Male 188 217 251 291 328 386 377 397 419 379 386 381 348 390 415 444 448 406 387 446 348 443

Female 172 181 198 229 263 231 257 271 264 267 257 258 240 281 260 283 270 290 295 319 285 289

Unknown



White 308 338 369 430 488 503 512 547 523 497 511 509 465 526 494 536 546 517 506 596 473 557

African American 46 55 68 73 85 96 103 97 126 119 101 98 96 109 148 149 133 137 138 140 126 121

Native American . * * * 11 * * * * * * 15 * * 12 13 * * * * * 15

Asian * * * * * * * 12 16 22 24 17 16 26 18 24 25 28 22 15 17 25

Other/unknown * * * * * * * * * * * . * * * * * * * * * 14



†Hispanic . . . . . . . . . . . . . . . 102 112 112 115 134 121 158

†Non-Hispanic . . . . . . . . . . . . . . . 625 606 584 567 631 512 574



Deceased 207 217 263 288 290 343 350 362 386 346 354 285 271 293 366 326 330 306 293 352 280 288

Living 115 140 168 201 258 244 257 287 276 292 278 343 309 366 301 389 377 371 374 397 347 434

Unknown 38 41 18 31 43 30 27 19 21 * 11 11 * 12 * 12 11 19 15 16 * *



1st transplant 307 353 383 434 492 507 514 535 564 525 530 527 505 585 560 634 627 614 584 674 567 669

2nd transplant 50 37 54 78 84 87 98 105 101 105 93 96 68 74 100 75 73 65 84 75 57 55

3rd transplant * * * * 12 20 18 23 16 14 19 13 14 11 14 11 14 16 13 15 * *

4th transplant . . * * * * * * * * * * * * * * * * * * . *

5th transplant . . . . . . * . . . . . . . . . . . . . . .



Blood type A . . . . . . . . 269 224 235 252 217 248 265 257 255 242 214 269 249 274

Blood type B . . . . . . . . 68 82 82 52 65 86 73 100 73 80 89 94 79 85

Blood type AB . . . . . . . . 26 20 21 25 31 33 21 25 33 26 28 17 29 33

Blood type O . . . . . . . . 297 310 291 295 266 290 308 333 346 329 333 369 270 330

Unknown type 360 398 449 520 591 617 634 668 23 * 14 15 * 14 * 12 11 19 18 16 * *



All 360 398 449 520 591 617 634 668 683 646 643 639 588 671 675 727 718 696 682 765 633 732

2002 2003 2004 2005 2006 2007 2008 2009

* * * * * * * *

117 119 122 134 132 136 121 152

147 148 121 138 128 128 125 150

238 281 246 292 271 244 239 256

269 264 273 329 359 288 287 315



477 479 445 525 520 476 434 513

299 335 323 373 378 323 341 364







580 581 539 636 585 514 524 559

150 166 150 167 175 138 134 127

* * 11 * 19 29 15 15

27 37 21 24 75 94 88 155

* 22 47 62 44 24 14 21



160 164 172 193 216 217 211 211

616 650 596 705 682 582 564 666



326 383 382 473 584 499 481 535

442 428 381 424 311 300 294 337

* * * * * . . *



683 728 702 812 810 733 713 792

87 78 60 78 77 62 52 80

* * * * 11 * * *

* * * * . . . .

. . . . . . . .



274 295 269 310 307 259 251 285

80 104 95 108 117 94 95 97

30 32 26 30 34 31 29 30

384 380 373 449 437 415 400 460

* * * * * . . *



776 814 768 898 898 799 775 877

Table E.8

Counts of renal transplants, by donor type

by age, gender, race, ethnicity,primary cause of ESRD, blood type, PRA, number of transplants, cytomegalovirus (CMV) antibody status, hepatitis C antibody status, & Epstein-Barr virus (EBV) antibody status



ALL

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997

<1 * 11 17 21 27 32 28 40 41 42 26 36 35 46 29 33 33 37

1-4 * 20 38 47 50 57 58 80 69 59 75 73 70 80 53 60 85 88

5-9 67 77 83 79 100 126 114 127 114 135 135 153 111 133 122 141 141 126

10-17 274 290 311 373 414 402 434 421 459 410 407 377 372 412 471 493 459 445

18-29 1,126 1,200 1,393 1,535 1,602 1,731 1,947 1,815 1,733 1,805 1,885 1,845 1,720 1,815 1,759 1,722 1,652 1,612

30-39 1,019 1,244 1,472 1,753 1,975 2,111 2,511 2,332 2,474 2,352 2,542 2,575 2,615 2,688 2,732 2,878 2,690 2,644

40-49 792 844 1,080 1,182 1,422 1,694 1,977 2,090 2,157 2,173 2,433 2,569 2,601 2,798 2,934 3,065 3,295 3,266

50-59 436 479 631 761 928 1,053 1,380 1,485 1,516 1,525 1,727 1,723 1,846 2,049 2,209 2,335 2,470 2,774

60-64 34 52 77 93 174 220 313 368 451 432 500 573 591 690 670 820 888 965

65-69 16 13 * 27 35 61 95 150 184 175 232 277 330 343 386 452 512 533

70-79 * * * * 12 13 26 32 46 42 75 71 113 118 140 168 175 189

80-84 . . . . * * * * . . . * * * * * * *

85+ * . . . . * * . * * * * * . . * * .

* * * * * * . * . . . . . * . . . .

0-17 360 398 449 520 591 617 634 668 683 646 643 639 588 671 675 727 718 696

18-44 2,561 2,911 3,442 3,923 4,352 4,735 5,489 5,286 5,340 5,353 5,769 5,836 5,721 5,965 5,995 6,119 5,922 5,848

45-64 846 908 1,211 1,401 1,749 2,074 2,639 2,804 2,991 2,934 3,318 3,449 3,652 4,075 4,309 4,701 5,073 5,413

65-74 18 15 * 30 45 69 118 176 221 209 295 343 422 445 512 597 670 689

75+ * . . * * * * * * * 16 * 28 19 16 25 20 35

* * * * * * . * . . . . . * . . . .

Male 2,351 2,698 3,239 3,672 4,214 4,669 5,508 5,516 5,615 5,516 6,002 6,151 6,147 6,685 6,925 7,390 7,379 7,562

Female 1,436 1,534 1,874 2,204 2,526 2,838 3,379 3,425 3,627 3,633 4,039 4,123 4,264 4,491 4,582 4,779 5,024 5,119

* * . . * * * * * * . * . . . . . .

White 2,967 3,285 3,924 4,476 5,158 5,696 6,772 6,780 6,857 6,894 7,536 7,727 7,735 8,330 8,174 8,765 8,901 9,125

African American 706 801 1,030 1,196 1,359 1,570 1,811 1,796 1,930 1,867 2,043 2,097 2,177 2,330 2,723 2,826 2,872 2,884

Native American 17 32 35 41 54 72 71 73 109 100 91 111 99 114 141 122 135 129

Asian 37 55 88 113 131 131 196 245 275 259 331 322 386 381 453 429 466 505

61 60 36 50 40 39 38 48 74 31 40 18 14 21 16 27 29 38

†Hispanic 120 131 211 273 304 432 519 555 753 784 870 927 974 1,051 1,040 1,164 1,240 1,343

†Non-Hispanic 3,668 4,102 4,902 5,603 6,438 7,076 8,369 8,387 8,492 8,367 9,171 9,348 9,437 10,125 10,467 11,005 11,163 11,338



Diabetes 419 570 814 951 1,191 1,464 1,857 1,824 1,903 2,016 2,249 2,442 2,404 2,859 2,913 3,101 3,257 3,294

Hypertension 429 523 711 837 926 1,121 1,327 1,394 1,492 1,444 1,661 1,723 1,899 1,946 2,171 2,175 2,176 2,174

Glomerulonephritis 1,224 1,342 1,680 1,918 2,247 2,350 2,665 2,730 2,717 2,731 2,963 2,983 2,916 3,002 3,061 3,328 3,308 3,406

Other cause 1,716 1,798 1,908 2,170 2,378 2,573 3,039 2,994 3,133 2,960 3,168 3,127 3,192 3,369 3,362 3,565 3,662 3,807



Blood type A 3,478 3,353 3,831 3,870 3,827 4,284 4,315 4,622 4,817 4,908

Blood type B 1,032 1,060 1,120 1,154 1,144 1,290 1,322 1,431 1,406 1,522

Blood type AB 406 387 431 442 480 457 530 576 570 556

Blood type O 4,108 4,063 4,317 4,506 4,698 4,982 5,221 5,360 5,461 5,564

Unknown type 3,788 4,233 5,113 5,876 6,742 7,508 8,888 8,942 221 288 342 303 262 163 119 180 149 131



PRA = 0% 5,197 5,203 5,978 6,372 6,746 7,413 7,743 8,460 8,738 9,257

PRA 1-19% 2,365 2,448 2,459 2,564 2,344 2,515 2,568 2,365 2,318 2,083

PRA 20-79% 1,092 943 921 834 749 759 791 804 857 884

PRA 80-100% 279 273 251 206 236 221 224 271 247 234

Unknown PRA 3,788 4,233 5,113 5,876 6,742 7,508 8,881 7,426 312 284 432 299 336 268 181 269 243 223



1st transplant 3,351 3,801 4,561 5,123 5,729 6,343 7,615 7,719 7,966 7,921 8,669 8,911 9,087 9,884 10,105 10,637 10,920 11,170

2nd transplant 407 388 497 679 881 1,023 1,132 1,062 1,110 1,081 1,163 1,179 1,120 1,126 1,218 1,324 1,252 1,295

3rd transplant 30 42 50 67 117 126 129 140 159 127 184 166 181 145 162 172 199 193

4th+ transplant . * * * 15 16 12 21 * 22 25 19 23 21 22 36 32 23



CMV antibody: R+/D+ . . . . . . . . . . . . . . . . 4,061 4,320

CMV antibody: R+/D- . . . . . . . . . . . . . . . . 2,444 2,459

CMV antibody: R+/D? . . . . . . . . . . . . . . . . 156 206

CMV antibody: R-/D+ . . . . . . . . . . . . . . . . 2,171 2,152

CMV antibody: R-/D- . . . . . . . . . . . . . . . . 2,127 2,135

CMV antibody: R-/D? . . . . . . . . . . . . . . . . 142 125

CMV antibody: R?/D+ . . . . . . . . . . . . . . . . 548 570

CMV antibody: R?/D- . . . . . . . . . . . . . . . . 413 394

CMV antibody: R?/D? 3,788 4,233 5,113 5,876 6,742 7,508 8,888 8,942 9,245 9,151 10,041 10,275 10,411 11,176 11,507 12,169 341 319



Hep C antibody: R+/D+ . . . . . . . . . . . . . . . . 121 110

Hep C antibody: R+/D- . . . . . . . . . . . . . . . . 517 539

Hep C antibody: R+/D? . . . . . . . . . . . . . . . . * 14

Hep C antibody: R-/D+ . . . . . . . . . . . . . . . . 53 71

Hep C antibody: R-/D- . . . . . . . . . . . . . . . . 10,046 10,311

Hep C antibody: R-/D? . . . . . . . . . . . . . . . . 234 183

Hep C antibody: R?/D+ . . . . . . . . . . . . . . . . 18 11

Hep C antibody: R?/D- . . . . . . . . . . . . . . . . 1,050 1,122

Hep C antibody: R?/D? 3,788 4,233 5,113 5,876 6,742 7,508 8,888 8,942 9,245 9,151 10,041 10,275 10,411 11,176 11,507 12,169 354 319



EBV antibody: R+/D+ . . . . . . . . . . . . . . . . 12 13

EBV antibody: R+/D- . . . . . . . . . . . . . . . . . *

EBV antibody: R+/D? . . . . . . . . . . . . . . . . 125 247

EBV antibody: R-/D+ . . . . . . . . . . . . . . . . * *

EBV antibody: R-/D- . . . . . . . . . . . . . . . . . *

EBV antibody: R-/D? . . . . . . . . . . . . . . . . 32 50

EBV antibody: R?/D+ . . . . . . . . . . . . . . . . 12 43

EBV antibody: R?/D- . . . . . . . . . . . . . . . . * *

EBV antibody: R?/D? 3,788 4,233 5,113 5,876 6,742 7,508 8,888 8,942 9,245 9,151 10,041 10,275 10,411 11,176 11,507 12,169 12,212 12,320



All 3,788 4,233 5,113 5,876 6,742 7,508 8,888 8,942 9,245 9,151 10,041 10,275 10,411 11,176 11,507 12,169 12,403 12,681

rr virus (EBV) antibody status





1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009

41 46 29 48 45 38 42 47 51 47 35 41

58 81 69 83 77 83 86 92 89 92 89 115

137 130 106 134 147 148 121 138 128 128 125 150

446 508 429 467 507 545 519 621 630 532 526 571

1,623 1,675 1,634 1,606 1,483 1,531 1,581 1,523 1,565 1,401 1,448 1,365

2,901 2,700 2,800 2,840 2,851 2,699 2,822 2,640 2,622 2,511 2,349 2,394

3,418 3,431 3,669 3,704 3,706 3,707 3,864 3,889 3,873 3,720 3,601 3,675

3,079 3,171 3,468 3,707 3,971 4,081 4,420 4,515 4,827 4,701 4,556 4,579

982 1,148 1,212 1,352 1,422 1,557 1,634 1,802 1,885 1,996 2,159 2,170

676 684 824 853 986 1,096 1,196 1,336 1,478 1,434 1,529 1,603

242 275 389 436 549 587 645 815 884 916 970 1,021

* * * * * 16 24 38 33 36 27 45

* * * * * * * * * * * *

. * . . . . * . * * . .

682 765 633 732 776 814 768 898 898 799 775 877

6,231 6,057 6,188 6,186 6,074 5,974 6,179 5,990 5,964 5,679 5,419 5,444

5,772 6,068 6,595 7,023 7,359 7,601 8,142 8,379 8,808 8,650 8,694 8,739

874 919 1,156 1,194 1,415 1,557 1,720 1,969 2,156 2,125 2,274 2,386

53 47 68 104 129 143 147 222 244 267 254 290

. * . . . . * . * * . .

8,026 8,241 8,655 9,022 9,340 9,617 10,127 10,508 11,080 10,745 10,630 10,693

5,586 5,616 5,985 6,217 6,413 6,472 6,830 6,950 6,991 6,776 6,786 7,043

. . . . . . . . . . . .

9,884 9,941 10,507 10,817 11,225 11,198 11,541 11,740 11,967 11,424 11,316 11,327

2,997 3,114 3,274 3,508 3,618 3,800 3,957 4,187 4,365 4,288 4,272 4,384

121 174 155 162 153 163 185 178 245 237 245 293

559 572 622 671 695 761 839 878 1,123 1,369 1,396 1,541

51 56 82 81 62 167 435 475 371 203 187 191

1,581 1,604 1,766 1,886 2,056 2,105 2,270 2,367 2,495 2,490 2,578 2,600

12,031 12,253 12,874 13,353 13,697 13,984 14,687 15,091 15,576 15,031 14,838 15,136



3,654 3,646 3,854 4,095 4,353 4,344 4,672 4,820 4,889 4,852 4,841 4,841

2,247 2,241 2,441 2,634 2,729 2,672 2,973 3,144 3,300 3,287 3,281 3,349

3,632 3,674 3,829 3,791 3,948 3,978 4,130 4,032 4,185 3,831 3,725 3,655

4,079 4,296 4,516 4,719 4,723 5,095 5,182 5,462 5,697 5,551 5,569 5,891



5,131 5,283 5,570 5,813 5,974 5,933 6,269 6,552 6,705 6,421 6,470 6,529

1,670 1,764 1,775 1,851 1,947 1,982 2,166 2,221 2,354 2,193 2,359 2,302

608 677 656 702 725 708 740 809 862 861 803 835

5,994 5,959 6,525 6,787 7,028 7,376 7,707 7,798 8,086 8,017 7,721 8,011

209 174 114 86 79 90 75 78 64 29 63 59



10,082 10,221 11,013 11,662 12,079 12,357 12,239 12,404 12,654 12,464 11,903 11,449

2,059 2,064 2,115 2,039 2,033 1,887 2,366 2,534 2,578 2,274 2,540 2,630

900 911 964 1,002 1,073 1,208 1,558 1,613 1,855 1,815 1,939 2,361

229 302 318 359 406 449 616 749 868 875 937 1,193

342 359 230 177 162 188 178 158 116 93 97 103



11,930 12,229 12,880 13,450 13,882 14,176 14,878 15,382 15,916 15,572 15,506 15,678

1,435 1,393 1,518 1,520 1,604 1,641 1,766 1,767 1,842 1,666 1,650 1,752

211 200 209 228 228 239 263 266 268 240 228 258

36 35 33 41 39 33 50 43 45 43 32 48



4,580 4,658 4,964 5,382 5,532 5,907 6,063 6,437 6,878 6,584 6,595 6,975

2,679 2,652 2,826 3,051 3,421 3,327 3,446 3,509 3,680 3,631 3,755 3,870

288 221 304 253 296 299 370 311 307 344 297 265

2,337 2,368 2,417 2,622 2,649 2,757 2,789 2,982 3,215 3,249 3,155 3,147

2,221 2,209 2,425 2,584 2,672 2,670 2,556 2,683 2,793 2,739 2,814 2,948

190 196 192 195 199 162 216 163 226 253 206 181

572 716 698 583 486 465 690 644 486 372 281 174

384 466 478 348 324 296 468 423 320 267 210 103

358 369 336 221 174 202 357 304 164 82 103 71



132 141 140 142 162 183 196 168 166 201 208 234

538 553 575 619 616 624 648 687 757 790 617 617

13 15 16 15 16 19 16 13 27 19 16 21

73 62 76 61 75 58 64 69 73 76 80 71

11,103 10,981 11,811 12,867 13,261 13,585 13,389 14,061 14,549 14,331 14,784 15,491

243 298 383 344 338 329 502 461 515 566 506 521

25 25 23 31 20 29 28 32 28 34 18 13

1,113 1,399 1,315 927 986 890 1,541 1,533 1,570 1,261 1,003 577

369 381 301 233 279 368 571 432 384 243 184 189



64 512 1,414 2,018 2,267 2,270 2,443 3,024 6,087 7,261 8,542 9,845

12 100 187 175 202 189 288 341 811 897 802 973

580 2,298 4,436 4,834 5,392 5,761 6,139 6,489 4,039 1,724 1,279 893

17 99 204 235 242 233 274 341 906 1,794 1,859 1,932

* 107 145 168 108 124 126 168 248 327 246 300

207 808 1,131 1,068 976 1,048 1,117 1,072 876 568 370 197

125 286 359 253 272 396 279 428 1,669 2,886 2,856 2,264

15 86 108 77 44 55 61 124 254 324 226 233

12,580 9,559 6,656 6,411 6,250 6,009 6,228 5,469 3,179 1,740 1,236 1,097



13,612 13,857 14,640 15,239 15,753 16,089 16,957 17,458 18,071 17,521 17,416 17,736

Table E.8 (continued)

Counts of renal transplants, by donor type

by age, gender, race, ethnicity,primary cause of ESRD, blood type, PRA, number of transplants, cytomegalovirus (CMV) antibody status, hepatitis C antibody status, Epstein-Barr virus (EBV) antibody status, & cold ischemia time



DECEASED DONOR

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997

<1 * * * 14 11 22 14 20 15 15 * * 14 * 12 * * *

1-4 * 11 21 25 25 34 30 36 38 30 43 28 32 29 25 24 37 32

5-9 35 46 46 43 46 67 60 73 68 76 72 65 43 68 60 57 69 62

10-17 161 153 187 206 208 220 246 233 265 225 230 183 182 188 269 241 216 204

18-29 672 750 805 923 1,022 1,064 1,193 1,142 1,146 1,238 1,263 1,195 1,094 1,110 1,031 1,062 918 869

30-39 689 837 1,011 1,222 1,371 1,416 1,655 1,624 1,930 1,805 1,943 1,918 1,907 1,943 1,939 1,986 1,820 1,742

40-49 600 634 790 874 1,060 1,180 1,327 1,477 1,842 1,817 2,019 2,068 2,041 2,197 2,260 2,289 2,387 2,376

50-59 366 373 460 556 697 736 961 1,054 1,339 1,318 1,500 1,456 1,501 1,655 1,764 1,787 1,870 2,035

60-64 30 48 62 76 137 155 225 275 419 379 452 508 504 579 558 648 703 718

65-69 13 * * 22 25 40 55 109 172 166 205 254 275 302 336 370 406 416

70-79 * * . * * * 12 17 41 34 64 62 98 105 126 139 147 156

80-84 . . . . * . . . . . . * * * * * * *

85+ . . . . . * . . * * * . * . . * * .

* . * * * * . * . . . . . * . . . .

0-17 207 217 263 288 290 343 350 362 386 346 354 285 271 293 366 326 330 306

18-44 1,675 1,936 2,237 2,607 2,978 3,117 3,517 3,561 4,027 4,038 4,292 4,242 4,086 4,188 4,107 4,157 3,878 3,746

45-64 682 706 891 1,044 1,309 1,434 1,844 2,011 2,649 2,519 2,885 2,903 2,961 3,296 3,445 3,615 3,820 3,994

65-74 15 11 * 24 30 44 67 125 206 194 262 312 356 393 448 493 538 544

75+ . . . * * * . * * * * * 20 16 16 18 18 30

* . * * * * . * . . . . . * . . . .

Male 1,635 1,864 2,149 2,524 2,905 3,120 3,645 3,761 4,416 4,308 4,742 4,697 4,606 4,927 5,125 5,345 5,171 5,199

Female 944 1,005 1,251 1,441 1,705 1,824 2,132 2,299 2,857 2,794 3,060 3,049 3,088 3,260 3,257 3,264 3,413 3,421

* * . . . . * * * * . * . . . . . .

White 1,954 2,156 2,533 2,925 3,411 3,612 4,248 4,469 5,235 5,193 5,651 5,650 5,506 5,913 5,751 5,981 5,884 5,872

African American 541 617 767 906 1,058 1,184 1,354 1,362 1,665 1,596 1,786 1,743 1,788 1,877 2,179 2,223 2,230 2,274

Native American 11 15 19 20 34 35 35 38 80 73 66 76 76 88 102 77 98 77

Asian 25 35 54 71 78 85 117 155 232 214 274 265 315 295 342 317 357 383

49 47 27 43 29 28 24 37 64 28 25 13 * 14 * 11 15 14

†Hispanic 62 73 133 161 175 238 251 339 574 588 657 679 681 718 698 780 790 829

†Non-Hispanic 2,518 2,797 3,267 3,804 4,435 4,706 5,527 5,722 6,702 6,516 7,145 7,068 7,013 7,469 7,684 7,829 7,794 7,791



Diabetes 290 393 537 625 823 958 1,217 1,260 1,499 1,600 1,759 1,878 1,861 2,240 2,254 2,387 2,443 2,483

Hypertension 307 368 505 608 665 781 921 1,026 1,265 1,205 1,429 1,404 1,500 1,533 1,695 1,660 1,643 1,642

Glomerulonephritis 795 863 1,063 1,242 1,496 1,516 1,685 1,813 2,055 2,042 2,206 2,207 2,091 2,103 2,103 2,213 2,131 2,110

Other cause 1,188 1,246 1,295 1,490 1,626 1,689 1,955 1,962 2,457 2,257 2,408 2,258 2,242 2,311 2,330 2,349 2,367 2,385



Blood type A 2,745 2,646 3,045 2,911 2,877 3,171 3,132 3,277 3,414 3,323

Blood type B 837 836 867 885 853 938 957 1,012 924 1,026

Blood type AB 333 322 345 353 391 356 418 440 459 420

Blood type O 3,293 3,158 3,370 3,446 3,500 3,701 3,874 3,865 3,771 3,842

Unknown type 2,580 2,870 3,400 3,965 4,610 4,944 5,778 6,061 68 142 175 152 73 21 * 15 16 *



PRA = 0% 4,101 4,000 4,739 4,751 4,998 5,397 5,670 6,014 5,984 6,244

PRA 1-19% 1,923 2,010 2,001 2,070 1,848 1,952 1,918 1,774 1,710 1,482

PRA 20-79% 945 816 782 709 611 631 608 601 677 695

PRA 80-100% 235 244 212 177 209 184 186 217 210 197

Unknown PRA 2,580 2,870 3,400 3,965 4,610 4,944 5,778 4,640 72 34 68 40 28 23 . * * *



1st transplant 2,255 2,517 2,977 3,402 3,849 4,063 4,864 5,165 6,209 6,074 6,634 6,637 6,617 7,181 7,301 7,458 7,496 7,497

2nd transplant 302 316 377 506 669 769 799 776 925 896 989 957 901 877 940 980 916 951

3rd transplant 23 36 41 51 82 97 107 105 133 115 157 136 157 113 121 140 147 151

4th+ transplant . * * * * 15 * 15 * 19 22 17 19 16 20 31 25 21



CMV antibody: R+/D+ . . . . . . . . . . . . . . . . 3,006 3,077

CMV antibody: R+/D- . . . . . . . . . . . . . . . . 1,853 1,822

CMV antibody: R+/D? . . . . . . . . . . . . . . . . 28 71

CMV antibody: R-/D+ . . . . . . . . . . . . . . . . 1,662 1,559

CMV antibody: R-/D- . . . . . . . . . . . . . . . . 1,209 1,240

CMV antibody: R-/D? . . . . . . . . . . . . . . . . 25 39

CMV antibody: R?/D+ . . . . . . . . . . . . . . . . 421 457

CMV antibody: R?/D- . . . . . . . . . . . . . . . . 285 280

CMV antibody: R?/D? 2,580 2,870 3,400 3,965 4,610 4,944 5,778 6,061 7,276 7,104 7,802 7,747 7,694 8,187 8,382 8,609 95 75



Hep C antibody: R+/D+ . . . . . . . . . . . . . . . . 116 108

Hep C antibody: R+/D- . . . . . . . . . . . . . . . . 412 416

Hep C antibody: R+/D? . . . . . . . . . . . . . . . . * *

Hep C antibody: R-/D+ . . . . . . . . . . . . . . . . 40 51

Hep C antibody: R-/D- . . . . . . . . . . . . . . . . 7,026 7,032

Hep C antibody: R-/D? . . . . . . . . . . . . . . . . 60 50

Hep C antibody: R?/D+ . . . . . . . . . . . . . . . . 15 *

Hep C antibody: R?/D- . . . . . . . . . . . . . . . . 816 886

Hep C antibody: R?/D? 2,580 2,870 3,400 3,965 4,610 4,944 5,778 6,061 7,276 7,104 7,802 7,747 7,694 8,187 8,382 8,609 98 64



EBV antibody: R+/D+ . . . . . . . . . . . . . . . . . .

EBV antibody: R+/D- . . . . . . . . . . . . . . . . . .

EBV antibody: R+/D? . . . . . . . . . . . . . . . . 90 170

EBV antibody: R-/D+ . . . . . . . . . . . . . . . . . .

EBV antibody: R-/D- . . . . . . . . . . . . . . . . . .

EBV antibody: R-/D? . . . . . . . . . . . . . . . . 20 34

EBV antibody: R?/D+ . . . . . . . . . . . . . . . . . .

EBV antibody: R?/D- . . . . . . . . . . . . . . . . . .

EBV antibody: R?/D? 2,580 2,870 3,400 3,965 4,610 4,944 5,778 6,061 7,276 7,104 7,802 7,747 7,694 8,187 8,382 8,609 8,474 8,416



0-12 hours . . . . . . . . . . . . . . . . 1,513 1,644

12-24 hours . . . . . . . . . . . . . . . . 4,429 4,540

25-36 hours . . . . . . . . . . . . . . . . 2,000 1,817

37+ hours . . . . . . . . . . . . . . . . 333 258

Unknown cold ischemia time 2,580 2,870 3,400 3,965 4,610 4,944 5,778 6,061 7,276 7,104 7,802 7,747 7,694 8,187 8,382 8,609 309 361



All 2,580 2,870 3,400 3,965 4,610 4,944 5,778 6,061 7,276 7,104 7,802 7,747 7,694 8,187 8,382 8,609 8,584 8,620

virus (EBV) antibody status, & cold ischemia time





1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009

* * * * * * 11 * 18 21 16 23

24 32 24 24 30 28 31 42 49 50 42 63

66 57 45 56 67 68 56 74 81 75 84 85

195 253 205 198 224 279 284 347 436 353 339 364

848 832 815 725 687 645 677 690 716 651 704 605

1,842 1,733 1,695 1,670 1,678 1,511 1,642 1,554 1,559 1,558 1,425 1,414

2,383 2,289 2,270 2,265 2,264 2,222 2,394 2,413 2,448 2,379 2,314 2,287

2,190 2,195 2,270 2,385 2,520 2,553 2,772 2,876 3,214 3,170 3,071 3,019

720 836 826 871 948 1,034 1,086 1,231 1,307 1,412 1,522 1,520

526 520 587 593 641 742 798 938 1,073 1,046 1,109 1,136

195 214 285 314 372 424 466 606 643 699 733 736

* * * * * 15 17 30 27 31 24 34

* * * * * . * . * * * *

. * . . . . . . * * . .

293 352 280 288 326 383 382 473 584 499 481 535

3,867 3,691 3,573 3,454 3,391 3,159 3,386 3,378 3,360 3,352 3,192 3,059

4,116 4,194 4,303 4,462 4,706 4,806 5,185 5,386 5,884 5,818 5,844 5,786

686 698 831 835 923 1,070 1,178 1,409 1,567 1,573 1,662 1,699

43 41 48 77 97 111 105 165 180 207 206 212

. * . . . . . . * * . .

5,401 5,387 5,421 5,458 5,641 5,818 6,156 6,557 7,083 7,081 6,963 6,775

3,604 3,590 3,614 3,658 3,802 3,711 4,080 4,254 4,493 4,369 4,422 4,516

. . . . . . . . . . . .

6,178 6,099 6,052 6,005 6,186 6,052 6,399 6,664 7,028 6,882 6,824 6,602

2,313 2,329 2,449 2,566 2,676 2,783 2,909 3,164 3,420 3,451 3,439 3,535

85 118 110 87 101 103 132 128 159 146 160 184

408 407 399 425 450 510 589 615 718 805 822 830

21 24 25 33 30 81 207 240 251 166 140 140

1,000 994 1,044 1,144 1,250 1,273 1,419 1,522 1,643 1,699 1,770 1,659

8,005 7,983 7,991 7,972 8,193 8,256 8,817 9,289 9,933 9,751 9,615 9,632



2,653 2,647 2,648 2,729 2,906 2,940 3,163 3,370 3,443 3,540 3,554 3,496

1,638 1,585 1,652 1,818 1,816 1,791 1,987 2,175 2,370 2,412 2,369 2,340

2,245 2,217 2,245 2,110 2,205 2,145 2,344 2,300 2,472 2,277 2,211 2,121

2,469 2,528 2,490 2,459 2,516 2,653 2,742 2,966 3,291 3,221 3,251 3,334



3,459 3,446 3,500 3,523 3,643 3,503 3,756 4,021 4,221 4,082 4,188 4,107

1,110 1,145 1,079 1,098 1,139 1,118 1,333 1,367 1,513 1,436 1,578 1,458

421 509 450 485 491 469 485 571 621 612 569 591

3,998 3,859 4,000 4,007 4,165 4,438 4,661 4,852 5,220 5,319 5,050 5,135

17 18 * * * * * . * * . .



6,729 6,608 6,705 6,908 7,204 7,275 7,322 7,697 8,022 8,091 7,773 7,051

1,408 1,413 1,358 1,219 1,169 1,071 1,358 1,465 1,617 1,409 1,545 1,578

669 698 707 701 739 833 1,088 1,085 1,259 1,246 1,321 1,708

188 255 264 288 329 350 468 564 678 702 745 954

11 * * . * . . . . * * .



7,833 7,852 7,825 7,963 8,269 8,403 8,904 9,506 10,153 10,136 10,144 9,964

993 952 1,039 979 1,002 951 1,119 1,109 1,222 1,128 1,057 1,118

153 149 144 147 146 153 180 170 177 158 164 174

26 24 27 27 26 22 33 26 24 28 20 35



3,290 3,260 3,350 3,363 3,454 3,706 3,970 4,377 4,773 4,657 4,610 4,839

1,904 1,870 1,923 2,013 2,278 2,180 2,238 2,278 2,460 2,551 2,653 2,613

83 26 19 * 44 31 * 29 53 40 31 19

1,676 1,707 1,614 1,698 1,738 1,782 1,884 2,021 2,258 2,286 2,214 2,120

1,218 1,181 1,240 1,301 1,289 1,233 1,211 1,227 1,388 1,497 1,491 1,494

46 13 15 * 11 17 * * 24 26 22 *

448 568 539 470 389 358 585 554 379 238 222 133

264 308 326 254 237 220 338 316 233 151 138 66

76 44 * * * * . * * * * .



122 134 135 134 158 183 192 166 161 195 205 234

410 427 423 444 451 446 481 517 600 555 478 466

* * * * * * * * * * * .

51 46 53 30 45 20 25 37 32 30 29 24

7,421 7,158 7,381 7,727 7,915 8,033 8,195 8,727 9,308 9,691 9,907 10,130

51 54 26 12 47 52 26 18 71 * * .

24 23 20 30 17 28 28 30 22 30 12 13

860 1,081 984 732 805 761 1,286 1,314 1,365 941 749 424

61 51 * * * * * * 11 * . .



. . . . . . 15 305 3,094 4,730 5,778 6,549

. . * . . * * 44 513 646 573 619

390 1,881 3,648 3,969 4,503 4,872 5,297 5,669 3,318 1,092 679 357

. . . . . . * 40 483 1,271 1,341 1,387

. . * . . . * * 84 175 110 149

145 652 931 850 791 847 914 922 687 307 108 32

. . . . . . * 111 1,336 2,432 2,437 1,977

. . . . . * * 12 177 270 186 144

8,470 6,444 4,454 4,297 4,149 3,808 3,994 3,702 1,884 527 173 77



1,741 1,750 1,818 1,953 2,236 2,467 2,580 2,940 3,492 3,488 3,508 3,920

4,473 4,228 4,140 4,021 4,342 4,225 4,701 4,922 5,180 5,273 5,307 5,106

1,866 1,621 1,471 1,378 1,290 1,265 1,349 1,498 1,524 1,498 1,490 1,256

275 225 205 206 201 179 166 237 306 374 422 383

650 1,153 1,401 1,558 1,374 1,393 1,440 1,214 1,074 817 658 626



9,005 8,977 9,035 9,116 9,443 9,529 10,236 10,811 11,576 11,450 11,385 11,291

Table E.8 (continued)

Counts of renal transplants, by donor type

by age, gender, race, ethnicity,primary cause of ESRD, blood type, PRA, number of transplants, cytomegalovirus (CMV) antibody status, hepatitis C antibody status, Epstein-Barr virus (EBV) antibody status, & donor relation



LIVING DONOR

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997

<1 * * * * 15 * 13 17 23 27 16 26 20 37 17 29 25 28

1-4 * * 16 20 24 21 27 43 27 28 31 44 38 51 27 36 48 54

5-9 25 20 33 28 46 51 48 50 41 57 59 85 67 65 59 82 71 60

10-17 82 107 113 147 173 162 169 177 185 180 172 188 184 213 198 242 233 229

18-29 350 371 537 554 528 606 688 616 567 544 595 621 596 677 712 630 710 722

30-39 249 355 420 475 553 630 780 672 508 519 562 628 667 719 765 846 844 880

40-49 152 172 261 284 335 465 607 584 286 323 384 475 524 569 645 738 870 864

50-59 46 93 150 178 214 299 397 405 162 188 212 250 314 383 421 530 577 728

60-64 . * 14 13 36 62 81 86 29 46 39 62 81 106 107 154 182 228

65-69 * * * * * 13 35 34 * * 22 19 49 41 46 81 102 114

70-79 . . . * * * * * . . * * * 11 12 27 25 33

80-84 . . . . . . . . . . . . . * . . . .

85+ * . . . . . * . . . * . * . . . . .

. . . . . * . . . . . . . . . . . .

0-17 115 140 168 201 258 244 257 287 276 292 278 343 309 366 301 389 377 371

18-44 683 819 1,098 1,187 1,256 1,460 1,811 1,608 1,241 1,245 1,393 1,525 1,550 1,705 1,822 1,859 1,975 2,046

45-64 114 176 284 317 410 602 742 755 311 375 399 511 632 749 828 1,039 1,208 1,376

65-74 * * * * * 15 42 40 * * 25 23 52 51 58 102 125 142

75+ * . . . . * * * . . * . * * . * * *

. . . . . * . . . . . . . . . . . .

Male 542 689 991 1,032 1,190 1,408 1,724 1,633 1,113 1,136 1,184 1,378 1,438 1,689 1,732 1,945 2,123 2,291

Female 373 448 560 679 738 916 1,132 1,058 725 783 914 1,024 1,106 1,184 1,277 1,450 1,564 1,649

. . . . * * . . . . . . . . . . . .

White 790 962 1,273 1,402 1,599 1,915 2,341 2,166 1,536 1,618 1,780 1,994 2,113 2,339 2,344 2,678 2,932 3,175

African American 104 132 224 248 256 324 392 394 231 228 227 319 337 425 511 552 606 578

Native American * 15 16 18 19 36 34 34 28 27 25 30 22 25 39 44 36 50

Asian * 15 29 36 46 41 76 87 35 43 53 54 68 80 108 108 102 116

* 13 * * * * 13 * * * 13 * * * * 13 11 21

†Hispanic 43 46 62 95 111 175 246 199 165 181 201 238 286 319 334 366 436 498

†Non-Hispanic 872 1,091 1,489 1,616 1,819 2,150 2,610 2,492 1,673 1,738 1,897 2,164 2,258 2,554 2,675 3,029 3,251 3,442



Diabetes 108 150 264 295 339 470 592 539 386 391 460 542 499 598 635 680 787 783

Hypertension 81 119 181 202 234 298 368 342 201 213 201 284 357 389 451 476 503 509

Glomerulonephritis 323 398 560 597 683 754 904 856 618 645 717 746 779 864 926 1,065 1,133 1,265

Other cause 403 470 546 617 674 803 992 954 633 670 720 830 909 1,022 997 1,174 1,264 1,383



Blood type A 733 707 786 959 950 1,113 1,183 1,345 1,403 1,585

Blood type B 195 224 253 269 291 352 365 419 482 496

Blood type AB 73 65 86 89 89 101 112 136 111 136

Blood type O 815 905 947 1,060 1,198 1,281 1,347 1,495 1,690 1,722

Unknown type 915 1,137 1,551 1,711 1,930 2,325 2,856 2,691 22 18 26 25 16 26 * . * *



PRA = 0% 1,096 1,203 1,239 1,621 1,747 2,016 2,073 2,446 2,754 3,013

PRA 1-19% 442 437 458 494 496 563 650 591 608 601

PRA 20-79% 147 127 139 125 138 128 183 203 180 189

PRA 80-100% 44 29 39 29 27 37 38 54 37 37

Unknown PRA 915 1,137 1,551 1,711 1,930 2,325 2,849 2,597 109 123 223 133 136 129 65 101 108 100



1st transplant 857 1,086 1,456 1,577 1,750 2,106 2,554 2,425 1,683 1,787 1,947 2,206 2,351 2,639 2,749 3,092 3,369 3,622

2nd transplant 54 49 89 124 155 198 280 238 140 122 133 173 174 205 227 277 273 284

3rd transplant * * * * 20 20 18 24 15 * 16 21 16 25 31 23 41 32

4th+ transplant . . . . * * * * . * * * * * * * * *



CMV antibody: R+/D+ . . . . . . . . . . . . . . . . 1,055 1,243

CMV antibody: R+/D- . . . . . . . . . . . . . . . . 591 637

CMV antibody: R+/D? . . . . . . . . . . . . . . . . 128 135

CMV antibody: R-/D+ . . . . . . . . . . . . . . . . 509 593

CMV antibody: R-/D- . . . . . . . . . . . . . . . . 918 895

CMV antibody: R-/D? . . . . . . . . . . . . . . . . 117 86

CMV antibody: R?/D+ . . . . . . . . . . . . . . . . 127 113

CMV antibody: R?/D- . . . . . . . . . . . . . . . . 128 114

CMV antibody: R?/D? 915 1,137 1,551 1,711 1,930 2,325 2,856 2,691 1,838 1,919 2,098 2,402 2,544 2,873 3,009 3,395 114 123



Hep C antibody: R+/D+ . . . . . . . . . . . . . . . . * *

Hep C antibody: R+/D- . . . . . . . . . . . . . . . . 105 123

Hep C antibody: R+/D? . . . . . . . . . . . . . . . . * *

Hep C antibody: R-/D+ . . . . . . . . . . . . . . . . 13 20

Hep C antibody: R-/D- . . . . . . . . . . . . . . . . 3,020 3,279

Hep C antibody: R-/D? . . . . . . . . . . . . . . . . 174 133

Hep C antibody: R?/D+ . . . . . . . . . . . . . . . . * *

Hep C antibody: R?/D- . . . . . . . . . . . . . . . . 234 236

Hep C antibody: R?/D? 915 1,137 1,551 1,711 1,930 2,325 2,856 2,691 1,838 1,919 2,098 2,402 2,544 2,873 3,009 3,395 124 134



EBV antibody: R+/D+ . . . . . . . . . . . . . . . . 12 13

EBV antibody: R+/D- . . . . . . . . . . . . . . . . . *

EBV antibody: R+/D? . . . . . . . . . . . . . . . . 35 77

EBV antibody: R-/D+ . . . . . . . . . . . . . . . . * *

EBV antibody: R-/D- . . . . . . . . . . . . . . . . . *

EBV antibody: R-/D? . . . . . . . . . . . . . . . . 12 16

EBV antibody: R?/D+ . . . . . . . . . . . . . . . . 12 43

EBV antibody: R?/D- . . . . . . . . . . . . . . . . * *

EBV antibody: R?/D? 915 1,137 1,551 1,711 1,930 2,325 2,856 2,691 1,838 1,919 2,098 2,402 2,544 2,873 3,009 3,395 3,606 3,783



Living Related 1,648 1,731 1,776 2,192 2,260 2,458 2,375 2,793 2,840 3,001

Living Unrelated 108 116 135 154 229 289 338 596 802 891

Living Unknown 915 1,137 1,551 1,711 1,930 2,325 2,856 2,691 82 72 187 56 55 126 296 * 45 48



All 915 1,137 1,551 1,711 1,930 2,325 2,856 2,691 1,838 1,919 2,098 2,402 2,544 2,873 3,009 3,395 3,687 3,940

virus (EBV) antibody status, & donor relation





1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009

33 35 23 38 40 30 31 37 33 26 19 18

32 49 43 59 47 55 55 50 40 42 47 52

68 70 60 76 79 79 65 64 47 53 41 64

241 243 221 261 276 264 230 273 191 179 187 203

744 821 798 865 782 880 893 822 841 750 729 753

1,018 937 1,078 1,154 1,155 1,165 1,162 1,072 1,049 947 915 973

990 1,104 1,372 1,417 1,428 1,462 1,456 1,452 1,413 1,332 1,270 1,379

854 946 1,177 1,312 1,438 1,505 1,638 1,622 1,602 1,524 1,473 1,545

251 303 383 477 472 521 543 566 571 584 632 647

145 160 235 257 342 350 393 396 401 385 419 460

46 58 103 122 175 160 176 208 238 214 233 281

. * * * * * * * * * * 11

. . . . . * . * * * . *

. . . . . . * . . . . .

374 397 347 434 442 428 381 424 311 300 294 337

2,272 2,298 2,549 2,692 2,641 2,778 2,752 2,576 2,575 2,314 2,192 2,366

1,585 1,813 2,259 2,533 2,634 2,755 2,940 2,958 2,901 2,823 2,827 2,931

182 214 323 356 487 480 534 557 584 548 608 676

* * 19 27 32 32 41 55 62 58 47 78

. . . . . . * . . . . .

2,518 2,768 3,171 3,515 3,658 3,751 3,932 3,904 3,960 3,650 3,625 3,887

1,904 1,960 2,326 2,527 2,578 2,722 2,717 2,666 2,473 2,393 2,343 2,501

. . . . . . . . . . . .

3,572 3,735 4,385 4,756 4,987 5,094 5,092 5,027 4,895 4,521 4,454 4,680

639 747 790 924 925 988 1,029 1,001 931 833 810 843

35 55 45 75 52 60 53 50 86 91 84 107

148 161 220 241 240 245 247 258 401 562 573 707

28 30 57 46 32 86 228 234 120 36 47 51

558 581 709 738 796 819 842 836 839 786 802 931

3,864 4,147 4,788 5,304 5,440 5,654 5,807 5,734 5,594 5,257 5,166 5,457



954 970 1,174 1,343 1,424 1,369 1,488 1,420 1,425 1,307 1,273 1,337

580 619 772 800 898 862 971 958 919 867 896 999

1,332 1,412 1,558 1,667 1,730 1,818 1,769 1,714 1,700 1,547 1,499 1,524

1,556 1,727 1,993 2,232 2,184 2,424 2,421 2,478 2,389 2,322 2,300 2,528



1,672 1,837 2,070 2,290 2,331 2,430 2,513 2,531 2,484 2,339 2,282 2,422

560 619 696 753 808 864 833 854 841 757 781 844

187 168 206 217 234 239 255 238 241 249 234 244

1,996 2,100 2,525 2,780 2,863 2,938 3,046 2,946 2,866 2,698 2,671 2,876

* * . * . * * * * . . *



3,353 3,613 4,308 4,754 4,875 5,082 4,917 4,707 4,632 4,373 4,130 4,398

651 651 757 820 864 816 1,008 1,069 961 865 995 1,052

231 213 257 301 334 375 470 528 596 569 618 653

41 47 54 71 77 99 148 185 190 173 192 238

146 204 121 96 86 101 106 81 54 63 33 47



4,019 4,317 5,001 5,437 5,584 5,743 5,953 5,854 5,744 5,429 5,355 5,694

352 360 431 513 565 644 600 608 586 520 542 598

43 41 59 78 75 75 79 93 84 80 60 84

* * * 14 12 11 17 15 19 14 11 12



1,290 1,398 1,614 2,019 2,078 2,201 2,093 2,060 2,105 1,927 1,985 2,136

775 782 903 1,038 1,143 1,147 1,208 1,231 1,220 1,080 1,102 1,257

205 195 285 247 252 268 365 282 254 304 266 246

661 661 803 924 911 975 905 961 957 963 941 1,027

1,003 1,028 1,185 1,283 1,383 1,437 1,345 1,456 1,405 1,242 1,323 1,454

144 183 177 190 188 145 211 156 202 227 184 174

124 148 159 113 97 107 105 90 107 134 59 41

120 158 152 94 87 76 130 107 87 116 72 37

97 173 219 134 97 113 285 225 94 50 36 14



* * * * * . * * * * * .

128 126 152 175 165 178 167 170 157 235 139 151

* 12 12 13 15 14 15 12 21 17 15 21

22 16 23 31 30 38 39 32 41 46 51 47

3,682 3,823 4,430 5,140 5,346 5,552 5,194 5,334 5,241 4,640 4,877 5,361

192 244 357 332 291 277 476 443 444 562 502 521

* * * * * * . * * * * .

253 318 331 195 181 129 255 219 205 320 254 153

123 178 184 147 201 280 497 354 311 213 121 132



64 512 1,414 2,018 2,267 2,270 2,428 2,719 2,993 2,531 2,764 3,296

12 100 186 175 202 188 287 297 298 251 229 354

190 417 788 865 889 889 842 820 721 632 600 536

17 99 204 235 242 233 272 301 423 523 518 545

* 107 144 168 108 124 124 162 164 152 136 151

62 156 200 218 185 201 203 150 189 261 262 165

125 286 359 253 272 396 269 317 333 454 419 287

15 86 108 77 44 54 60 112 77 54 40 89

3,925 2,963 2,094 2,033 2,027 2,114 2,162 1,690 1,233 1,185 1,000 963



3,158 3,289 3,618 3,884 3,848 3,848 3,831 3,697 3,510 3,181 3,045 3,146

1,208 1,408 1,877 2,150 2,388 2,621 2,816 2,871 2,920 2,856 2,921 3,238

56 31 * * . * * * * * * *



4,422 4,728 5,497 6,042 6,236 6,473 6,649 6,570 6,433 6,043 5,968 6,388

Table E.9

Renal transplant rates, by donor type

by age, gender, race, ethnicity, & primary diagnosis, per 100 dialysis patient years, unadjusted



ALL

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001

<1 77.4 73.3 56.2 66.8 57.7 52.9 47.2 70.4 63.9 54.3 34.2 49.5 51.2 56.1 33.6 41.4 44.1 49.9 52.3 52.6 36.1 48.4

1-4 36.6 51.0 67.8 59.7 62.4 68.6 58.0 63.3 72.2 55.7 71.3 61.4 54.8 64.9 39.8 43.8 57.7 58.3 45.7 60.4 48.7 61.5

5-9 54.4 58.4 54.5 52.6 58.2 76.8 62.3 64.5 56.2 62.9 59.5 63.6 53.9 58.0 47.5 51.5 52.4 52.2 50.0 50.9 42.9 45.3

10-17 31.2 33.3 35.2 39.6 44.7 44.1 50.4 49.2 47.3 44.0 41.5 38.5 35.8 37.5 45.4 45.7 40.1 38.3 38.3 45.5 38.1 39.4

18-29 21.5 21.8 24.0 25.7 25.3 26.3 29.7 27.2 25.2 24.2 23.9 22.8 20.3 20.9 19.0 18.5 17.1 16.5 16.2 16.1 15.6 15.2

30-39 14.9 16.2 17.0 18.4 19.3 19.5 21.6 19.3 18.9 17.0 16.9 15.9 14.9 14.4 13.8 13.8 12.7 12.1 13.0 11.7 11.9 11.8

40-49 9.5 9.1 10.5 10.6 11.7 13.1 14.7 14.6 13.7 12.1 12.3 11.7 10.7 10.5 10.1 9.7 9.6 9.1 8.9 8.5 8.6 8.4

50-59 3.5 3.4 4.0 4.4 5.0 5.5 6.9 7.1 7.0 6.5 6.8 6.2 6.0 6.1 6.0 6.0 5.9 6.0 6.2 5.9 5.9 6.0

60-64 0.5 0.7 0.8 0.9 1.4 1.7 2.2 2.4 2.8 2.6 2.7 2.9 2.9 3.1 2.9 3.2 3.4 3.4 3.3 3.6 3.6 3.8

65-69 0.2 0.2 . 0.3 0.3 0.5 0.7 1.0 1.1 0.9 1.2 1.2 1.3 1.3 1.3 1.5 1.6 1.6 1.9 1.9 2.2 2.2

70-79 . . . . 0.1 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.4 0.5 0.6

80-84 . . . . 0.1 0.1 0.2 . . . . . . . . . . . 0.1 . 0.1 .

85+ 0.8 . . . . 0.4 . 0.1 0.1 0.1 0.2 0.1 0.1 . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . .

0-17 35.0 37.9 39.8 43.4 48.3 50.7 52.5 53.9 51.4 48.4 46.2 45.0 40.8 43.8 44.4 46.2 43.8 42.8 41.5 47.9 39.5 42.6

18-44 16.1 16.7 18.1 19.1 19.5 20.3 22.4 20.6 19.5 17.9 17.9 16.7 15.3 14.9 14.1 13.9 12.8 12.2 12.5 11.8 11.7 11.5

45-64 3.7 3.4 4.0 4.2 4.9 5.4 6.6 6.7 6.6 6.0 6.2 5.9 5.7 5.9 5.7 5.7 5.8 5.8 5.8 5.6 5.7 5.8

65-74 0.2 0.1 . 0.2 0.3 0.3 0.5 0.7 0.8 0.6 0.8 0.8 0.9 0.9 0.9 1.0 1.0 1.0 1.2 1.2 1.5 1.5

75+ . . . . 0.1 0.1 0.1 0.1 0.1 0.1 0.1 . 0.1 0.1 . 0.1 . 0.1 0.1 0.1 0.1 0.2

. . . . . . . . . . . . . . . . . . . . . .

Male 8.5 8.8 9.3 9.5 9.8 10.0 11.0 10.3 9.6 8.6 8.5 7.8 7.1 7.1 6.7 6.6 6.2 5.9 5.9 5.6 5.6 5.5

Female 6.3 5.9 6.3 6.5 6.7 6.9 7.5 7.0 6.7 6.1 6.1 5.6 5.3 5.1 4.8 4.6 4.6 4.4 4.5 4.3 4.3 4.3

. . . . . . . . . . . . . . . . . . . . . .

White 8.6 8.6 9.1 9.4 9.8 10.1 11.3 10.6 9.9 9.2 9.1 8.5 7.8 7.8 7.1 7.1 6.8 6.6 6.7 6.4 6.4 6.2

African American 4.8 4.7 5.2 5.3 5.2 5.4 5.7 5.1 5.0 4.3 4.2 3.8 3.6 3.5 3.7 3.5 3.4 3.2 3.1 3.0 3.0 3.1

Native American 6.0 8.7 7.6 6.8 7.2 8.4 7.1 6.4 8.2 6.7 5.4 5.8 4.5 4.6 5.2 4.1 4.2 3.7 3.2 4.3 3.6 3.6

Asian 11.9 13.5 14.3 13.6 12.2 9.6 11.7 12.5 11.7 9.3 10.0 8.2 8.3 6.9 7.0 5.9 5.7 5.7 5.7 5.4 5.3 5.4

. . . . . . . . . . . . . . . . . . . . . .

†Hispanic 11.1 9.4 12.2 13.2 12.0 14.3 14.3 12.8 13.8 11.4 10.3 9.4 8.4 7.5 6.3 6.0 5.3 5.0 5.3 4.9 4.8 4.7

†Non-Hispanic 7.4 7.4 7.8 7.9 8.2 8.3 9.2 8.5 7.9 7.2 7.2 6.6 6.0 6.0 5.7 5.6 5.4 5.2 5.2 5.0 5.0 5.0

. . . . . . . . . . . . . . . . . . . . . .

Diabetes 9.3 9.5 9.7 8.9 8.9 9.0 9.7 8.2 7.3 6.6 6.2 5.6 4.8 5.0 4.5 4.3 4.1 3.7 3.7 3.4 3.4 3.4

Hypertension 5.2 5.1 5.4 5.2 4.9 5.1 5.4 5.0 4.8 4.1 4.1 3.8 3.7 3.5 3.5 3.3 3.2 3.1 3.0 2.9 3.0 3.1

Glomerulonephritis 11.4 11.2 12.2 12.3 13.0 12.6 13.5 13.0 12.2 11.5 11.7 11.1 10.3 10.0 9.6 10.0 9.4 9.3 9.5 9.3 9.5 9.2

Other cause 6.3 6.3 6.6 7.2 7.6 8.2 9.7 9.5 9.6 8.8 9.2 8.7 8.4 8.6 8.1 8.2 7.9 7.9 8.0 8.0 7.9 7.9



All 7.5 7.4 7.9 8.1 8.3 8.5 9.4 8.7 8.2 7.4 7.4 6.8 6.2 6.1 5.8 5.7 5.4 5.2 5.2 5.0 5.0 4.9

2002 2003 2004 2005 2006 2007 2008 2009

51.2 48.3 42.8 45.0 51.0 42.4 33.7 36.1

53.8 62.1 60.7 56.7 59.7 65.6 46.9 61.7

49.9 51.9 40.6 51.3 47.9 49.5 49.2 60.5

38.8 41.9 37.6 45.1 48.9 42.8 43.4 46.3

14.1 14.4 14.8 14.0 14.0 12.1 12.0 11.1

11.6 10.9 11.3 10.4 10.1 9.6 8.6 8.6

8.2 7.9 8.0 7.8 7.6 7.0 6.7 6.6

6.0 5.8 6.0 5.8 5.8 5.5 5.1 4.9

3.8 4.0 4.1 4.3 4.2 4.2 4.2 4.0

2.5 2.7 2.8 3.1 3.2 3.0 3.0 3.0

0.7 0.7 0.8 1.0 1.0 1.0 1.1 1.1

. 0.1 0.1 0.1 0.1 0.1 0.1 0.1

. . . . . . . .

. . . . . . . .

42.5 45.1 40.0 46.7 49.8 45.4 43.7 48.7

11.2 10.8 11.0 10.5 10.1 9.4 8.7 8.6

5.7 5.6 5.8 5.6 5.6 5.3 5.0 4.8

1.8 1.9 2.0 2.3 2.4 2.3 2.3 2.3

0.2 0.2 0.2 0.3 0.3 0.3 0.3 0.3

. . . . . . . .

5.4 5.3 5.3 5.3 5.3 4.9 4.6 4.5

4.3 4.2 4.2 4.2 4.1 3.8 3.7 3.7

. . . . . . . .

6.2 5.9 5.9 5.7 5.6 5.1 4.8 4.6

3.1 3.1 3.1 3.2 3.2 3.0 2.9 2.9

3.2 3.3 3.7 3.4 4.5 4.3 4.2 4.9

5.1 5.3 5.5 5.5 6.5 7.4 7.1 7.3

. . . . . . . .

4.7 4.5 4.6 4.5 4.4 4.1 4.0 3.8

4.9 4.8 4.9 4.8 4.8 4.5 4.2 4.2

. . . . . . . .

3.4 3.2 3.3 3.2 3.1 3.0 2.8 2.7

3.0 2.8 3.0 3.1 3.1 3.0 2.9 2.8

9.5 9.4 9.7 9.4 9.7 8.8 8.5 8.2

7.6 7.9 7.7 7.8 7.6 7.0 6.6 6.7



4.9 4.8 4.8 4.8 4.8 4.4 4.2 4.1

Table E.9 (continued)

Renal transplant rates, by donor type

by demographic characteristics, & primary diagnosis, per 100 dialysis patient-years, unadjusted



DECEASED DONORS

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001

<1 49.2 45.8 31.2 38.5 23.8 34.8 25.5 29.8 23.1 21.5 13.2 16.5 20.3 11.0 15.1 10.1 14.0 12.5 11.8 13.1 9.0 10.3

1-4 21.3 30.6 37.5 35.2 28.0 40.9 31.0 28.5 40.8 27.9 39.0 22.0 25.2 27.7 17.5 17.6 26.6 20.8 20.5 23.2 17.6 17.5

5-9 29.2 34.3 30.2 29.0 28.8 37.9 31.7 37.7 35.4 36.3 33.2 26.7 21.3 29.9 24.7 21.1 23.6 25.5 23.4 22.4 18.4 18.9

10-17 18.2 17.7 21.3 21.8 23.0 24.8 28.5 26.4 27.5 24.4 23.3 18.9 17.8 16.9 25.6 22.2 19.1 17.6 16.9 23.0 17.9 16.8

18-29 12.9 13.6 14.0 15.5 16.3 16.3 18.3 17.3 16.8 16.6 16.2 14.9 13.1 13.0 11.2 11.4 9.6 9.1 8.6 8.1 7.9 7.0

30-39 10.2 11.0 11.7 12.9 13.4 13.0 14.2 13.5 14.8 13.2 12.9 12.0 10.9 10.4 9.9 9.7 8.7 8.0 8.3 7.5 7.2 7.0

40-49 7.2 6.9 7.7 7.9 8.7 9.2 9.9 10.3 11.7 10.1 10.3 9.4 8.4 8.3 7.8 7.2 6.9 6.6 6.2 5.7 5.4 5.1

50-59 2.9 2.7 3.0 3.2 3.8 3.8 4.8 5.1 6.2 5.6 5.9 5.2 4.9 4.9 4.8 4.6 4.5 4.4 4.4 4.1 3.9 3.9

60-64 0.4 0.6 0.6 0.7 1.1 1.2 1.6 1.8 2.6 2.2 2.5 2.6 2.5 2.6 2.4 2.5 2.7 2.5 2.4 2.6 2.5 2.4

65-69 0.2 0.2 . 0.2 0.2 0.3 0.4 0.7 1.0 0.9 1.1 1.1 1.1 1.1 1.2 1.2 1.2 1.3 1.5 1.5 1.6 1.5

70-79 . . . . 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.2 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.4

80-84 . . . . 0.1 . . . . . . . . . . . . . 0.1 . . .

85+ . . . . . 0.4 . 0.1 0.1 0.1 0.1 . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . .

0-17 20.1 20.9 23.4 24.1 24.2 28.2 28.9 28.5 29.5 26.3 25.5 20.3 19.1 19.2 24.0 20.8 20.2 18.8 17.9 22.3 17.3 16.8

18-44 10.6 11.2 11.8 12.7 13.4 13.4 14.4 14.0 14.8 13.5 13.3 12.2 11.0 10.5 9.7 9.5 8.4 7.8 7.8 7.2 6.8 6.4

45-64 2.9 2.7 3.0 3.2 3.7 3.7 4.6 4.8 5.8 5.2 5.4 5.0 4.6 4.8 4.6 4.4 4.4 4.3 4.1 3.9 3.7 3.7

65-74 0.2 0.1 . 0.2 0.2 0.2 0.3 0.5 0.7 0.6 0.7 0.8 0.7 0.8 0.8 0.8 0.8 0.8 1.0 1.0 1.1 1.1

75+ . . . . . . . . 0.1 . 0.1 . 0.1 0.1 . . . 0.1 0.1 0.1 0.1 0.1

. . . . . . . . . . . . . . . . . . . . . .

Male 5.9 6.0 6.2 6.5 6.7 6.7 7.3 7.0 7.6 6.7 6.7 6.0 5.3 5.2 4.9 4.8 4.3 4.1 3.9 3.7 3.5 3.3

Female 4.1 3.9 4.2 4.3 4.5 4.4 4.7 4.7 5.3 4.7 4.7 4.2 3.8 3.7 3.4 3.2 3.1 2.9 2.9 2.7 2.6 2.5

. . . . . . . . . . . . . . . . . . . . . .

White 5.7 5.6 5.9 6.1 6.5 6.4 7.1 7.0 7.6 6.9 6.9 6.2 5.5 5.5 5.0 4.9 4.5 4.3 4.2 3.9 3.7 3.5

African American 3.7 3.6 3.9 4.0 4.1 4.1 4.3 3.9 4.3 3.7 3.7 3.2 2.9 2.8 3.0 2.8 2.6 2.5 2.4 2.2 2.2 2.3

Native American 3.9 4.1 4.1 3.3 4.5 4.1 3.5 3.3 6.0 4.9 3.9 4.0 3.5 3.6 3.7 2.6 3.0 2.2 2.3 2.9 2.5 1.9

Asian 8.0 8.6 8.8 8.5 7.2 6.2 7.0 7.9 9.9 7.7 8.2 6.8 6.8 5.4 5.3 4.3 4.4 4.3 4.2 3.8 3.4 3.4

. . . . . . . . . . . . . . . . . . . . . .

†Hispanic 5.7 5.3 7.7 7.8 6.9 7.9 6.9 7.8 10.5 8.6 7.8 6.9 5.9 5.1 4.3 4.0 3.4 3.1 3.4 3.0 2.8 2.8

†Non-Hispanic 5.1 5.0 5.2 5.4 5.7 5.5 6.1 5.8 6.3 5.6 5.6 5.0 4.5 4.4 4.2 4.0 3.8 3.6 3.5 3.3 3.1 3.0

. . . . . . . . . . . . . . . . . . . . . .

Diabetes 6.4 6.5 6.4 5.8 6.1 5.9 6.4 5.7 5.8 5.2 4.8 4.3 3.7 3.9 3.5 3.3 3.0 2.8 2.7 2.5 2.3 2.2

Hypertension 3.8 3.6 3.8 3.8 3.5 3.6 3.7 3.7 4.0 3.4 3.6 3.1 2.9 2.7 2.8 2.5 2.4 2.3 2.2 2.0 2.0 2.1

Glomerulonephritis 7.4 7.2 7.7 8.0 8.7 8.2 8.5 8.7 9.2 8.6 8.7 8.2 7.4 7.0 6.6 6.6 6.1 5.8 5.9 5.6 5.6 5.1

Other cause 4.4 4.4 4.4 4.9 5.2 5.4 6.2 6.2 7.5 6.7 7.0 6.3 5.9 5.9 5.6 5.4 5.1 5.0 4.8 4.7 4.4 4.1



All 5.1 5.0 5.3 5.5 5.7 5.6 6.1 5.9 6.5 5.8 5.7 5.1 4.6 4.5 4.2 4.0 3.7 3.5 3.5 3.2 3.1 3.0

2002 2003 2004 2005 2006 2007 2008 2009

7.4 12.7 10.7 12.8 20.2 20.6 14.9 20.9

23.9 24.8 21.9 25.4 37.1 35.4 23.8 32.0

21.3 24.2 20.1 26.5 29.3 29.4 31.9 36.1

16.8 20.5 20.3 25.4 33.5 28.3 28.1 29.4

6.7 6.2 6.4 6.4 6.5 5.6 5.7 5.0

6.8 6.2 6.6 6.2 6.0 6.0 5.3 5.2

5.0 4.8 4.9 4.8 4.8 4.5 4.3 4.1

3.8 3.6 3.8 3.7 3.9 3.7 3.4 3.2

2.6 2.7 2.7 2.9 2.9 2.9 3.0 2.8

1.6 1.8 1.9 2.2 2.3 2.2 2.2 2.1

0.5 0.5 0.6 0.7 0.8 0.8 0.8 0.8

. 0.1 0.1 0.1 0.1 0.1 0.1 0.1

. . . . . . . .

. . . . . . . .

17.4 20.8 19.7 24.6 32.2 28.4 27.2 29.8

6.3 5.8 6.0 5.9 5.7 5.6 5.2 4.8

3.7 3.6 3.7 3.6 3.8 3.6 3.4 3.2

1.2 1.3 1.4 1.6 1.7 1.7 1.7 1.7

0.1 0.1 0.1 0.2 0.2 0.2 0.2 0.2

. . . . . . . .

3.3 3.2 3.2 3.3 3.4 3.3 3.0 2.8

2.5 2.4 2.5 2.6 2.6 2.5 2.4 2.4

. . . . . . . .

3.4 3.2 3.2 3.3 3.3 3.1 2.9 2.7

2.3 2.3 2.3 2.4 2.5 2.4 2.3 2.3

2.1 2.1 2.6 2.4 3.0 2.6 2.8 3.1

3.3 3.5 3.9 3.8 4.2 4.4 4.2 4.0

. . . . . . . .

2.9 2.7 2.8 2.9 2.9 2.8 2.7 2.4

2.9 2.8 2.9 3.0 3.1 2.9 2.8 2.7

. . . . . . . .

2.2 2.2 2.2 2.3 2.2 2.2 2.1 2.0

2.0 1.9 2.0 2.1 2.3 2.2 2.1 2.0

5.3 5.1 5.5 5.4 5.7 5.2 5.0 4.8

4.0 4.1 4.1 4.2 4.4 4.1 3.9 3.8



2.9 2.8 2.9 3.0 3.0 2.9 2.8 2.6

Table E.9 (continued)

Renal transplant rates, by donor type

by demographic characteristics, & primary diagnosis, per 100 dialysis patient-years, unadjusted



ALL LIVING DONORS

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001

<1 28.1 27.5 18.7 24.3 32.3 18.1 20.4 36.5 36.7 32.8 20.9 32.0 29.8 44.1 18.5 31.2 30.1 36.4 39.5 38.5 27.1 38.1

1-4 15.2 20.4 28.6 23.0 31.8 23.2 25.0 33.9 27.5 27.0 31.4 38.5 29.6 37.2 21.5 26.1 31.1 36.1 24.4 37.3 29.5 44.1

5-9 19.0 16.1 21.8 18.1 25.1 33.9 27.9 24.8 18.9 25.7 24.7 35.2 32.2 27.8 21.7 29.3 28.5 24.7 25.2 27.1 24.2 25.7

10-17 9.4 12.4 12.5 15.7 18.4 17.2 19.8 21.0 18.9 19.0 17.6 19.0 17.4 19.7 19.4 22.6 20.1 19.8 20.5 21.6 19.8 21.8

18-29 6.7 6.8 9.2 9.2 8.2 9.2 10.4 9.1 8.1 7.2 7.4 7.6 6.9 7.6 7.6 6.8 7.3 7.2 7.3 7.8 7.5 8.1

30-39 3.6 4.6 4.8 4.9 5.4 5.9 6.7 5.5 3.8 3.6 3.7 3.7 3.8 3.8 3.8 4.0 3.9 4.0 4.5 4.0 4.6 4.7

40-49 1.8 1.9 2.5 2.5 2.7 3.6 4.4 4.1 1.8 1.8 1.8 2.2 2.2 2.1 2.2 2.3 2.5 2.4 2.6 2.7 3.2 3.2

50-59 0.4 0.6 0.9 1.0 1.1 1.6 2.0 2.0 0.7 0.8 0.9 0.9 1.0 1.1 1.1 1.3 1.4 1.6 1.7 1.8 2.0 2.1

60-64 . 0.1 0.2 0.1 0.3 0.5 0.6 0.6 0.2 0.3 0.2 0.3 0.4 0.5 0.5 0.6 0.7 0.8 0.8 0.9 1.1 1.4

65-69 . . . 0.1 0.1 0.1 0.3 0.2 0.1 . 0.1 0.1 0.2 0.2 0.1 0.3 0.3 0.3 0.4 0.4 0.6 0.7

70-79 . . . . . . 0.1 . . . . . . . . 0.1 0.1 0.1 0.1 0.1 0.1 0.2

80-84 . . . . . . 0.1 . . . . . . . . . . . . . . .

85+ 0.8 . . . . . . . . . 0.1 . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . .

0-17 11.1 13.5 14.6 16.7 20.8 19.9 21.4 23.6 20.5 21.5 20.0 23.9 21.2 23.8 19.9 24.6 23.0 22.9 22.6 24.7 21.7 25.2

18-44 4.3 4.6 5.7 5.7 5.6 6.3 7.3 6.2 4.5 4.1 4.3 4.3 4.1 4.2 4.3 4.2 4.3 4.2 4.5 4.4 4.8 5.0

45-64 0.5 0.7 1.0 1.0 1.1 1.5 1.9 1.8 0.7 0.8 0.7 0.9 1.0 1.1 1.1 1.3 1.4 1.5 1.6 1.7 2.0 2.1

65-74 . . . . . 0.1 0.2 0.2 . . 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.3 0.3 0.4 0.4

75+ . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . .

Male 2.0 2.2 2.9 2.7 2.8 3.0 3.4 3.1 1.9 1.8 1.7 1.8 1.7 1.8 1.7 1.7 1.8 1.8 1.8 1.9 2.0 2.1

Female 1.6 1.7 1.9 2.0 2.0 2.2 2.5 2.2 1.3 1.3 1.4 1.4 1.4 1.3 1.3 1.4 1.4 1.4 1.5 1.5 1.7 1.8

. . . . . . . . . . . . . . . . . . . . . .

White 2.3 2.5 3.0 2.9 3.0 3.4 3.9 3.4 2.2 2.2 2.2 2.2 2.1 2.2 2.0 2.2 2.3 2.3 2.4 2.4 2.7 2.7

African American 0.7 0.8 1.1 1.1 1.0 1.1 1.2 1.1 0.6 0.5 0.5 0.6 0.6 0.6 0.7 0.7 0.7 0.6 0.7 0.7 0.7 0.8

Native American 1.8 4.1 3.5 3.0 2.5 4.2 3.4 3.0 2.1 1.8 1.5 1.6 1.0 1.0 1.4 1.5 1.1 1.5 0.9 1.4 1.0 1.7

Asian 1.9 3.7 4.7 4.3 4.3 3.0 4.5 4.5 1.5 1.5 1.6 1.4 1.5 1.5 1.7 1.5 1.3 1.3 1.5 1.5 1.9 1.9

. . . . . . . . . . . . . . . . . . . . . .

†Hispanic 4.0 3.3 3.6 4.6 4.4 5.8 6.8 4.6 3.0 2.6 2.4 2.4 2.5 2.3 2.0 1.9 1.9 1.9 1.9 1.8 1.9 1.8

†Non-Hispanic 1.8 2.0 2.4 2.3 2.3 2.5 2.9 2.5 1.6 1.5 1.5 1.5 1.5 1.5 1.5 1.6 1.6 1.6 1.7 1.7 1.9 2.0

. . . . . . . . . . . . . . . . . . . . . .

Diabetes 2.4 2.5 3.2 2.7 2.5 2.9 3.1 2.4 1.5 1.3 1.3 1.3 1.0 1.0 1.0 0.9 1.0 0.9 1.0 0.9 1.0 1.1

Hypertension 1.0 1.2 1.4 1.3 1.2 1.4 1.5 1.2 0.6 0.6 0.5 0.6 0.7 0.7 0.7 0.7 0.7 0.7 0.8 0.8 0.9 0.9

Glomerulonephritis 3.0 3.3 4.1 3.8 4.0 4.1 4.6 4.1 2.8 2.7 2.8 2.8 2.8 2.9 2.9 3.2 3.2 3.5 3.5 3.6 3.9 4.1

Other cause 1.5 1.6 1.9 2.0 2.2 2.6 3.2 3.0 1.9 2.0 2.1 2.3 2.4 2.6 2.4 2.7 2.7 2.9 3.1 3.2 3.5 3.8



Related donor 1.5 1.4 1.3 1.4 1.4 1.3 1.2 1.3 1.2 1.2 1.2 1.2 1.2 1.3

Unrelated donor 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.3 0.4 0.4 0.5 0.5 0.6 0.7



All 1.8 2.0 2.4 2.4 2.4 2.6 3.0 2.6 1.6 1.6 1.5 1.6 1.5 1.6 1.5 1.6 1.6 1.6 1.7 1.7 1.9 2.0

2002 2003 2004 2005 2006 2007 2008 2009

43.7 35.6 32.1 32.3 30.7 21.9 18.8 15.2

29.9 37.2 38.8 31.3 22.7 30.2 23.2 29.7

28.3 27.4 20.1 24.8 18.6 20.1 17.3 23.9

21.5 21.2 17.0 19.5 15.2 14.5 15.2 16.5

7.2 8.2 8.3 7.5 7.4 6.5 6.1 6.1

4.7 4.7 4.7 4.2 4.1 3.6 3.3 3.4

3.2 3.1 3.0 2.9 2.8 2.5 2.4 2.5

2.1 2.2 2.2 2.1 1.9 1.8 1.6 1.7

1.3 1.3 1.4 1.3 1.3 1.2 1.2 1.1

0.9 0.9 0.9 0.9 0.9 0.8 0.8 0.9

0.2 0.2 0.2 0.2 0.3 0.2 0.3 0.3

. . . . . . . .

. . . . . . . .

. . . . . . . .

24.6 24.1 20.0 22.0 17.3 17.1 16.5 18.6

4.8 5.0 4.9 4.5 4.3 3.8 3.5 3.7

2.0 2.0 2.1 2.0 1.9 1.7 1.6 1.6

0.6 0.6 0.6 0.6 0.7 0.6 0.6 0.7

. . 0.1 0.1 0.1 0.1 0.1 0.1

. . . . . . . .

2.1 2.1 2.1 2.0 1.9 1.7 1.6 1.6

1.7 1.7 1.7 1.6 1.4 1.3 1.3 1.3

. . . . . . . .

2.7 2.7 2.6 2.5 2.3 2.0 1.9 1.9

0.8 0.8 0.8 0.8 0.7 0.6 0.6 0.6

1.1 1.2 1.1 1.0 1.6 1.6 1.5 1.8

1.8 1.7 1.6 1.6 2.3 3.1 2.9 3.4

. . . . . . . .

1.8 1.8 1.7 1.6 1.5 1.3 1.2 1.4

1.9 1.9 1.9 1.8 1.7 1.6 1.5 1.5

. . . . . . . .

1.1 1.0 1.0 1.0 0.9 0.8 0.7 0.7

1.0 0.9 1.0 0.9 0.9 0.8 0.8 0.8

4.1 4.3 4.2 4.0 3.9 3.6 3.4 3.4

3.5 3.8 3.6 3.5 3.2 2.9 2.7 2.9



1.2 1.1 1.1 1.0 0.9 0.8 0.7 0.7

0.7 0.8 0.8 0.8 0.8 0.7 0.7 0.8



1.9 1.9 1.9 1.8 1.7 1.5 1.4 1.5



Related docs
Other docs by cuiliqing
P-1 Area
Views: 0  |  Downloads: 0
server maps sep 07
Views: 6  |  Downloads: 0
MeetingPackage2
Views: 0  |  Downloads: 0
award_fy11
Views: 10  |  Downloads: 0
APPLICATION FOR A CHAPERONE LICENCE
Views: 1  |  Downloads: 0
273
Views: 0  |  Downloads: 0
PRE - HISTORY
Views: 0  |  Downloads: 0
By registering with docstoc.com you agree to our
privacy policy

You are almost ready to download!

You are almost ready to download!